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Effect of Hypertension on Pregnancy Outcomes at UNRWA Health Centers in Gaza 
Governorates: Comparative Study 
Abstract 
Pregnancy and childbirth are physiological and natural processes in women. However, 
these normal processes might be complicated by factors that affect the outcomes. In Gaza 
strip, hypertension affects 10 percent of all pregnant women. Hypertension may affect 
pregnancy and cause adverse outcomes for both mother and baby.  
Aim: This study aimed to identify the possible effect of hypertension on pregnancy 
outcomes and maternal adverse events among women attended UNRWA's health care 
services in Gaza Governorates, in order to reduce the incidence of adverse pregnancy 
outcomes and improve maternal and child health. 
Methods: analytical comparative study has been performed between August 2016 and May 
2017, on 430 mothers who attending United Nations Relief and Works Agency for 
Palestine Refugees in the Near East health centers, which divided into two groups (with 
and without hypertension in last pregnancy),  consisted of 215 mothers for each. Stratified 
sampling was used. Data collected through face to face interviewed questionnaire along 
with medical records revision. Moreover, the World Health Organization life quality scale 
was used. Statistical analysis was performed using Pearson's Chi-square and t-tests (p-
value< 0.05). Helsinki and managerial approval were granted and consent form was 
obtained from participants. 
Findings: the hypertensive mothers had statistically significant differences (p ≤ 0.05) in 
pregnancy termination (p=0.001) , antepartum  (p=0.001) and postpartum hemorrhage 
(p=0.003) and pre/eclampsia . In addition to 79.1% of mothers with pregnancy-induced-
hypertension (PIH) were recovered from HTN. Among newborn adverse outcomes, the 
significant differences were observed between the two groups in preterm birth (p=0.13), 
low birth weight (p=0.003) and neonatal admissions (p=0.044) all the differences were for 
the women with hypertension in the last pregnancy. Also, the hypertensive mothers had 
there significant differences in quality of life (p ≤ 0.05).  
Conclusion: The findings demonstrated that women with hypertension in pregnancy are at 
higher risk to have adverse fetomaternal outcomes compared to women without 
hypertension in Gaza Strip. Early diagnosis and quality prenatal follow-up are 
recommended to improve the maternal and fetal prognosis.  
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Chapter 1: Introduction 
 
1.1 Background 
The hypertensive disorders of pregnancy are a major health problem worldwide and affects 
individuals with a lot of complications, such as cardiovascular diseases and renal 
dysfunction (World Health Organization-WHO, 1987). The prevalence of hypertension in 
the United States for 2011–2014 among adults was 29.0% (Yoon et al., 2015). In Jordan, 
hypertension is a common and important public health problem with prevalence of 32.2% 
(Jaddou et al., 2011). Pregnancy and childbirth are physiological and natural processes in 
women. However, these normal processes might be complicated by factors that affect the 
outcomes. Among these factors is a hypertension. Hypertension is the most common 
medical condition associated with pregnancy. Globally, hypertensive disorders affects 10 
percent of all pregnant women (Duley, 2009), noting that the same findings (10%) was 
observed in Gaza Governorates (United Nations Relief and Works Agency for Palestine 
Refugees in the Near East-UNRWA, 2015).  
The hypertension in pregnancy is generally defined as a diastolic blood pressure of 90 mm 
Hg or more, and/or systolic blood pressure of 140 mm Hg or more and classified into: 
Preexisting hypertension, gestational hypertension, preexisting hypertension with 
superimposed preeclampsia and unclassified antenatally (Helewa et al., 1997). The 
incidence of Chronic Hypertension before pregnancy ranged between 1-5% among all 
pregnancies and Pregnancy-induced hypertension after 20 weeks of gestation was varies 
between 2-7% (UNRWA, 2009).  
In Qatar, the incidence of eclampsia in is 0.31 per 1000 deliveries and leads to an increase 
of perinatal morbidity which mainly related to Low birth weight (48.6%) of the cases and 
prematurity (Sharara, 2012). There may be a synergetic effect of both gestational 
hypertension and postpartum incident hypertension as women with both were at higher risk 
of cardiovascular events than were women with gestational or incident hypertension alone 
(Yeh et al., 2014). The severe hypertension in pregnancy is associated with worse maternal 
and fetal outcomes and had an important role in defining the outcomes (Cicero et al., 
2015).  
Hypertension may affect pregnancy and cause adverse outcomes for both mother and baby; 
maternal outcome could be superimposed preeclampsia on chronic hypertension, preterm 
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delivery, cesarean delivery, postpartum hemorrhage, Hemolysis, Elevated Lever enzyme 
and Low Platelets (HELLP) syndrome, disseminated intravascular coagulation, placental 
abruption, eclampsia, pulmonary edema, renal failure, cerebrovascular hemorrhage and 
maternal death and perinatal outcome could be abortion, low birth weight, intra uterine 
growth restriction, small for gestational age, intra uterine fetal death, stillbirth, neonatal 
admissions to hospitals and respiratory distress (Wongcharoenrut & Yamasmit, 2014). 
Hypertensive disorders of pregnancy and gestational diabetes increase the risk of 
premature vascular disease (Nerenberg et al., 2014). The women of hypertensive 
pregnancy disorders women may exhibit long–term worse blood pressure control and 
adverse left ventricular remodeling (Mesquita, 2014).  
A study conducted in Ethiopia, among the women with hypertension shows that 6.6% of 
patients with renal failure, 12.4 with HELLP syndrome, 35.5% with preeclampsia, chronic 
HTN 4.1%, 12.4% with gestational hypertension and 7.4% with postpartum hemorrhage 
(Seyom et al., 2015). Whereas, In India, retinal changes were found in 27.27% of women 
with pregnancy induced hypertension (Bhupally et al., 2015). 
Worldwide, the estimated maternal deaths was 287000 occurred in 2010 (WHO, 2012). 
Hypertension in pregnancy responsible about 18% of all maternal deaths, with an 
estimated 62000 – 77000 deaths per year (Khan et al., 2006). In Gaza Strip, the total 
maternal deaths was 10 cases during 2014, two of them were due to hemorrhage, cardiac 
(2), pulmonary embolism (2), septicemia (2), cancer (1) and acute respiratory distress (1) 
noting that some of these are related to hypertension in pregnancy (UNRWA, 2015).  
The stillbirth incidence was higher among women with eclampsia (15.3%), women with 
pre-eclampsia (6.4%) and women without pre-eclampsia/eclampsia (1.9%) (Abalos et al., 
2014). In Gaza Strip, during 2013 the neonatal mortality was 20.3 per 1000 live birth, 
among the main causes was preterm birth with 39% (van den Berg et al., 2015). 
Regarding the quality of life among hypertensive patients, Ha et al., found it was moderate, 
except psychological health was relatively low (Ha et al., 2014). 
 We hope this study will highlight the possible pregnancy outcomes that occurs in relation 
to hypertension, either maternal or newborns in United Nations Relief and Works Agency 
for Palestine Refugees in the Near East (UNRWA) health centers in GG. Moreover, to 
provide an evidence that accelerate and enhance the health care providers and decision 
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makers to improve maternal and child health. Accordingly, we can protect the future of 
Palestinian people in Gaza Governorates. 
1.2 Research Problem 
Hypertension in pregnancy, including pregnancy-induced hypertension and chronic 
hypertension, is one of the leading causes of pregnancy associated morbidity and even 
mortality. Moreover, HTN in pregnancy affects the psychological well-being and quality 
of life of women in productive age. According to United Nations Relief and Works 
Agency for Palestine Refugees in the Near East (UNRWA) statistics, the total number of 
newly registered pregnant women during 2014 was 39546, 10% of them had hypertension 
in pregnancy, among all pregnant women with HTN 24% were diagnosed as having HTN 
before pregnancy (UNRWA, 2015). The incidence of Chronic HTN ranged from1 to 5% 
from all pregnancies and PIH varies between 2-7% and the incidence of PIH is increased 
with increased placental mass such in twin or molar pregnancy. In Gaza Strip the neonatal 
mortality was increased from 12.0 (2008) to 20.3 per 1000 live birth (2013), among the 
main causes was preterm birth which accounted 39% (van den Berg et al., 2015).  
Unfortunately, in the Gaza Strip no complete data on the pregnancy adverse outcomes of 
the mother and newborn, we do not know exactly what are the complications of HTN on 
mother and newborn and what are the most prevalent adverse outcomes such as eclampsia, 
HELLP syndrome, ante- and post-partum hemorrhage, prematurity, LBW, neonatal 
admissions and etc. In other words, we do not know specifically which adverse outcomes 
may be occurred. So by conducting this study we will be able to predict the consequences 
of HTN in pregnancy in Gaza Governorates (GG).   
 
1.3 Justification 
During the literature search, the researcher found many studies about the adverse maternal 
and newborn outcomes were conducting in many countries around the world, but most of 
these studies were fragmented and discussed the outcomes separately. Unfortunately, the 
researcher couldn’t find such studies in Gaza Governorates concerning adverse outcomes 
in the mothers with hypertension in pregnancy , so this study considered as the first and 
baseline study in Gaza governorates that aimed to explore the possible adverse outcomes 
associated with HTN in pregnancy for the mother and newborn, as during 2015 the total 
number of pregnant women with HTN was 3860 and 24% of them were diagnosed before 
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pregnancy. The neonatal mortality was increased from 12.0 (2008) to 23.3 per 1000 live 
birth (2013), among the main causes was preterm birth which accounted 39% (van den 
Berg et al., 2015). About 58% of the hypertensive women were multiparous. 68 (98.5 %) 
were delivered by caesarean section, (43%) of them were carried out as an emergency 
procedure in Sudan (Kheir et al., 2014). Also The risk of preeclampsia was 2.3 times 
higher in first pregnancies than that in second or more pregnancies, the neonatal mortality 
rate (81 vs. 12 per 1000 live births), and prematurity (30.8% vs. 7%), and the rates of low 
birth wight delivery (32.5% vs. 8.3%) were significantly higher among women with 
preeclampsia (Khader et al., 2017). The most prevalent maternal outcomes were chronic 
HTN (12,06%), renal diseases (7.84%), Sepsis (5,28%), hepatic diseases (3.92%), Anemia 
(3.14%), maternal severe outcome more prevalent with women with eclampsia (18.06%), 
women with pre-eclampsia (4.31%), maternal deaths were higher with women with 
eclampsia (3.66%), women with pre-eclampsia 0.43% (Abalos et al., 2014). 
Therefore hypertension in pregnancy could be a reason for a different adverse maternal and 
newborn outcomes, in addition of affecting quality of life. So, by conducting this study we 
can generate information in order to improve maternal and child health care in Palestine 
and to give evidence to improve decision making processes at different levels of health 
care system. Moreover, it will be helpful for different researchers in future. 
1.4 Study Objectives 
1.4.1. Aim of the study 
The aim of the study is to identify the possible effect of pregnancy hypertension on 
pregnancy outcomes and maternal adverse events among women attended UNRWA's 
health care services in Gaza Governorates, in order to improve the quality of maternal and 
child health care services. 
1.4.2 Objectives 
1- To determine the effects of hypertension in pregnancy on maternal health. 
2- To determine the effects of hypertension in pregnancy on newborn's health. 
3- To explore the effect of hypertension in pregnancy on the quality of life.  
4- To formulate recommendations to promote and protect maternal and child health.  
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1.5 Research Questions  
1- Does the demographic variables affect the presence or the severity of newborn's or 
maternal adverse outcomes in women with HTN in pregnancy? 
2- Does the obstetric profile variables affect the presence or the severity of maternal 
or newborn's outcomes in women with HTN in pregnancy? 
3- What are the possible adverse effects of hypertension in pregnancy on maternal 
outcome? 
4- What are the possible adverse effects of hypertension in pregnancy on newborn's 
outcome? 
5- Does the HTN in pregnancy affect the quality of life? 
6- What are the applicable recommendations? 
1.6 Context of the study 
1.6.1 Socio-demographic context 
Historical Palestine have an area of 27.000 sq. km. and bordered by four countries Egypt, 
Jordan, Lebanon and Syria. In addition to the Mediterranean sea, Aqaba Gulf and the Dead 
sea. The Gaza Governorates is lying on the Mediterranean Sea as narrow piece of land; it is 
45 kilometers long and 6-12 kilometers wide with an area of 378 square kilometers 
(PASSIA, 2008).  
The total population of Gaza Strip and West Bank (WB) was about 4.81 million, 2,36 
million females and 2.45 million males (PCBS, 2016). The total number of the Palestinian 
population residing in the GG is around 1.88 million. The GG is considered the highest 
density in the world. The Palestinian central Bauru statics (PCBS) declared that the 
population density in the GG is more than 5154 inhabitants per one square kilometer and 
the majority of the GG population is refugees (66.8%) who receive basic primary health 
care services and some secondary care services through UNRWA (PCBS, 2016).  
The average life expectancy of the population in GG is 74.6 for females and 71.5 for male 
(PCBS, 2016). In Gaza Strip the percentage of individuals aged (0-14) constituted 43.0% 
of the total population at mid-2015. The elderly population aged (65 years and over) 
constituted 2.4% at the same time (PCBS, 2015). The growth rate in GG during 2015 was 
3.4%, fertility rate was 4.5 and family size was 5.7 (UNRWA, 2017). 
Gaza Governorates suffered from many recurrent occupations. After the end of the First 
World War, historical Palestine was placed under the British Mandate. Then the period 
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from 1948 to 1967 The Gaza strip was under the Egyptian Administration, in June 1967 it 
was occupied by the Israeli army. In 1994 the Israelis officially handled the Gaza strip to 
the Palestinian Authority according to Oslo agreement with partial autonomy that lead to 
improvement of the social and economic status of the people in Gaza till the setting up of 
Intifada in 2000 where the political and socioeconomic situation started to deteriorate. In 
June 2007 the life in Gaza reached to the catastrophic situation where a terrible event 
occurred “the internal division” and Gazan people started to suffer from its sequences; a 
tight siege has been imposed on the Gaza strip to control borders, movement of goods and 
travelers. During that Israel launched three large scale aggressions on the Gaza strip which 
resulted in thousands of deaths and injuries among people and damage of thousands of 
houses, manufacture compounds, agricultural resources (MOH, 2013).  
The economic situation in the Gaza strip has been deteriorated since 2006 as a result of a 
combination of siege, unemployment, restrictions on workers and industries which cause 
decline in living conditions and poor infrastructure. Also the basic services quality was 
affected such as health, education, shelter, and water. 54% of Gaza Strip population are 
food insecure (OCHA, 2012).  
The Palestinian central bureau of statistics (PCBS) stated that the main sources of 
livelihood in the GG are employment at the services sector mainly at government, 
UNRWA, nongovernmental organizations (NGOs), agriculture, livestock rearing and 
fishing (PCBS, 2015). During 2015 the Gross Domestic Product (GDP) was 1.7 (USD 
Billion), GDP Per Capita 971.1 USD and Unemployment 43.9% (PCBS, 2015). 
The deterioration of both economic and social status in the GG negatively affects the status 
of the Gazian population and the economic recovery became impossible as long as the 
Siege remains. it is will take years to repair the repeated damages to recover the economy. 
Furthermore, most of GG population depends on humanitarian aid provided by different 
relief agencies such as the World Food Program and UNRWA.  
1.6.3 Palestinian health care system 
In Palestine, the health care system is unique and complex as operating under a difficult 
circumstances like political instability, Israeli occupation and internal divide. there are five 
main providers for healthcare services, the Ministry of Health (MOH), United Nations 
Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), Non-
Governmental Organizations (NGOs), Palestinian Military Medical Services and the 
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private sector. MOH is the main health care provider; it has the responsibility for insuring 
equitable and affordable access to quality health services for all Palestinians and provides 
primary, secondary, and tertiary services and purchase advanced medical services through 
referring patients to the neighboring countries and other private and NGO health care 
facilities, it also play a role in providing and controlling immunization scheme, public 
health activities, licensing and registration of health facilities. MOH is the main primary 
health care provider that operates 472 primary health centers; 54 in GG, While NGOs 
manage 210 primary health centers; 81 in GG (MOH, 2011).  
While the UNRWA operates 137 primary health centers; 21 in GG and 42 in WB 
(UNRWA, 2013). 
Number of registered medical manpower in GG during 2014 for doctors, nurses, dentists 
and pharmacists was 3809, 7155, 1071 and 2562 respectively (PCBS, 2015). 
 In Palestine, the total number of hospitals was 81 hospitals, 63% (51) of them in West 
Bank (WB) and 37% (30) of hospitals in GG (MOH, 2017)  
The total Number of hospitals in GG was 30, out of them 13 for ministry of health, 14 for 
NGOS and 3 for military services. Total number of beds was 2999, of them 2243-ministry 
of health, 595-nongovernmental and 161-military services. Total number of deliveries was 
56386 of them 74.7% were at MOH hospitals . Governmental obstetric beds were 235 
(13.3%) in GG while the pediatric bed were 391 (22.2%) (MOH, 2017).  
The total number of deliveries in GG was 54,719 during 2016 in GG, around 80% 0f them 
was at governmental facilities. Preterm delivery percentage was 4.3% The percentages of 
C.S were 21.9% at ministry of health, 14.5% at NGOS and 12% at military hospitals 
(MOH, 2017). 
Bed occupancy rate at obstetric departments has reached to more than 100% in the past 
years (MOH, 2013). Obstetric beds per 10,000 ratio is only 2.1. In some NGO hospitals; 
the occupancy rate of the delivery bed is less than 30% (UNFPA, 2011). The maternal 
mortality ratio in the GG ranges between 20-40 per 100,000 live births which is still within 
the acceptable range by the WHO (50) (MOH, 2013). The most commonly reported health 
problems during pregnancy are infections (urinary tract infections and reproductive tract 
infections), anemia and pregnancy induced hypertension (UNFPA, 2011).  
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The timing of Ante Natal Care (ANC) visits is not always appropriate; about half of 
women did not receive ANC services within their first trimester and 7.9% did not benefit 
from ANC services till the last trimester. The percentage of women receiving Postnatal 
Care (PNC) has increased from 19.7% in 1996, to 40% currently but the quality of PNC 
services is an issue. The average stay of woman in the hospital after normal vaginal 
delivery is usually less than 2hrs and the reported CS rates is more than 20% of all 
deliveries (ibid).  
Hospital based child health services (for under 12 years) are provided by three hospitals 
specifically for pediatrics in addition to 11 hospitals providing child health services within 
its services. The total number of pediatric beds is around 560 beds; of them, 23 are 
pediatric intensive care beds, 106 neonatal care incubators and more than 50 daily care 
beds (MOH, 2012). The ratio of beds to child population is 8.5 beds per 10,000 (MOH, 
2013).  
In the GG the continuous Israel siege and the internal political division are strongly affect 
the provision of health care services is, while the primary and secondary health sector 
continue to function it faces many challenges as shortage of essential drugs and 
consumable at MOH facilities, 38% of essential drugs were out of stock at central store 
level at the beginning of January 2011 (MOH, 2011). At the end of 2011, 148 of 480 
essential drugs (31%) and 123 of 700 medical disposables (17.5%) were at zero stock in 
Gaza that put the patients at substantial risk of medical complications and deterioration in 
health status especially for cancer patients who are requiring on-going chemotherapy, 
patients with kidney diseases, transplants, hypertension, blood conditions and chronic 
illnesses who require a regular regime of medications, some of which are unavailable also 
exposed to special risk (EMRO, 2012). 
Regardless of previous, it is worth to mention that the health sector has exerted significant 
efforts not only to maintain health services but also to improve and present some new 
services such as opening of new specialized services at MOH hospitals as cardiac surgery 
and cardiac catheterization, introducing new schemes for health services as Family Health 
by UNRWA (MOH, 2011). 
1.6.4 UNRWA 
UNRWA is the United Nations Relief and Works Agency for Palestine Refugees in the 
Near East established by the General Assembly in 1949 following the first 1948 Arab-
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Israeli War, and became operational in 1950. The UNRWA mandate is to provide 
assistance and protection to a population of over 5 million registered Palestine refugees. 
The UNRWA mission is to help Palestine refugees in Jordan, Lebanon, Syria, West Bank 
and the Gaza Strip to achieve their full potential in human development (UNRWA, 2015). 
UNRWA provides health, education and relief services that becomes the largest 
humanitarian operation in the occupied Palestinian territory. Originally it intended to 
provide jobs on public works projects and direct relief for Palestinian Arabs who fled or 
were expelled by Israel gangs during the fighting that followed the end of the British 
mandate over Palestine. Today it provides education, health care, social services and 
emergency aid to some 5 million Palestinian refugees and it has been the main health care 
provider over 65 years that provides a comprehensive health care from maternal and child 
health care, infant care and immunizations, school health, oral health, consultations, 
diagnostic or laboratory services for management of non-communicable diseases 
(UNRWA, 2013).  
UNRWA is the second primary health care provider in the GG that plays an important role 
in health services delivery, providing free of charge PHC and purchasing secondary and 
tertiary services for the registered Palestinian refugees through 137 PHC centers, 21 of 
them located in GG and 1 hospital in Qalqelia in WB (UNRWA, 2015).  
In 2014 UNRWA medical officers provide almost 9.4 million medical consultations totally 
and almost 4.2 million of them were in GG only, in addition to about 700.000 dental 
consultations and about 220000 dental screening sessions. Moreover, UNRWA provides 
maternal and child health care through life cycle approach. Maternal health include, 
preconception care, antenatal care and family planning services (ibid). 
In GG during 2014 the total number of registered pregnant women was 39,546 with ANC 
coverage 87.3%, the percentage of pregnant women with at least 4 ANC visits was 91.7%, 
average number of antenatal visits per pregnant women (6.4), women of reproductive age 
15-49 years (25%), antenatal care coverage (87%), early pregnancy registration at first 
trimester (78.3%), the percentage of high and alert pregnancy was 40.1%, Diabetes and 
hypertension during pregnancy were 2.7% and 10% respectively, prevalence of anemia 
among pregnant women (35.6%), prevalence of anemia among nursing mothers (45.7%), 
number of total reported deliveries was 38096, reported abortions 2662, percentage of C-
Section among reported deliveries 17.4% and 10 maternal deaths, children < 1 year 
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registered (38584), mean birth interval (29.3months), percentage of women married by the 
age < 18 years (33%), mean marital age for women (19), percentage of women with birth 
intervals < 24 months (48.9), prevalence of exclusive breast feeding up to 4 months (33%), 
women attending postnatal care within 6 weeks of delivery (99.1%), registered children < 
1 year (38584), coverage of child health care (87%), underweight period prevalence for 
children 0 - 5 years (3.7%), 18 month old children that received 2 doses of Vitamin A 
100%, during 2013 the infant and neonatal mortality rates per 1000 live births were 22.4 
and 20.3 respectively (UNRWA, 2015).  
MOH in Gaza declared that during 2016 in GG, the total number of pregnant women was 
59538, around 68% of them was at governmental hospitals, 26.6% was at NGOS  and the 
average number of antenatal care visit was 7. High risk pregnancy reached 26.7%. the 
caesarian section was increased from 17% in 2010 to 2.8% in 2016.  
The post natal care was provided for 49041 women, 70.8% at UNRWA health centers 
19.4% at MOH health centers and 9.8% by home visit. Family planning services were 
provided to 17513 women (MOH, 2017).  
According to UNRWA Gaza field health office during 2015, the total number of pregnant 
women with HTN was 3860, among them 919 (24%) women were diagnosed as having 
HTN before pregnancy (UNRWA, 2015).  
UNRWA has around 11000 employees in GS, in which health department included around 
1001 health workers (ibid).  
In the recent years UNRWA health program faced many challenges, the main of them was 
its vertically-oriented health services through maternal and child care, non-communicable 
disease care and general clinical care such services are not integrated, this challenge faced 
the epidemiological transition among Palestinian people including refugees with a shift of 
diseases from communicable ones to non-communicable which appears in the higher rates 
of diseases including heart diseases, cancer, hypertension and cardiovascular diseases and 
diabetes mellitus which become the leading causes of death to general population including 
Palestinian refugees and account for 70 to 80% of causes of deaths (UNRWA, 2013). 
Addressing the above challenges UNRWA has begun the health reform in June 2011 by 
adopting the family health team (FHT) approach and e-health as the core strategy of the 
reform to strengthen primary health care(UNRWA, 2015). 
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Family Health Team (FHT) introduced as a primary care package focused on providing 
holistic and comprehensive primary health care for the entire family, depending on long-
term provider-patient/family relationships (person-centered approach). In order to improve 
effectiveness, efficiency and service delivery UNRWA adapted e-health which composed 
of the electronic medical records developed by UNRWA to improve patients’ data 
management and the improvement of the overall health services. The e.Health software 
contained four main modules: NCD, maternal health care, child health care, and outpatient, 
in addition to other support modules such as laboratory, pharmacy, dental and specialists 
(ibid). 
1.7 Operational Definitions 
Abruptio placenta: is defined as placental separation from the uterus with bleeding 
(concealed or vaginal) before delivery of the baby (ACOG, 2014). 
Adverse Maternal Outcomes: Any possible adverse outcomes for the mother such as 
Preeclampsia/eclampsia, mode of delivery (CS), antepartum hemorrhage (APH), 
postpartum hemorrhage (PPH), placenta abruption and HELLP Syndrome. 
Adverse Newborn outcome: Any possible adverse outcomes for the fetus and/or newborn 
such as stillbirth, neonatal death, neonatal admission, birth weight (especially LBW) and 
preterm birth. 
Antepartum Hemorrhage (APH) : hemorrhage from the genital tract after the twenty 
eighth week of pregnancy but before delivery the baby. 
Chronic Hypertension: defined as any HTN predates pregnancy or up to 20 weeks of 
gestation(ACOG, 2014). . 
Early neonatal death: The death of a live born during the first 7 days of life. 
Gestational age refers to the duration of gestation. It is measured from the first day of the 
last menstrual period and is expressed by completed weeks. 
HELLP Syndrome: a syndrome of  haemolysis (H) elevated liver enzymes (EL) and low 
platelet count (LP). 
Hypertension in pregnancy: an absolute level of blood pressure (140/90mmHg or 
greater) or by an increase in blood pressure from pre-conception or from first trimester 
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levels as systolic blood pressure rise by 25mmHg or greater and diastolic blood pressure 
rise by 15mmHg or more (UNRWA, 2009). 
Late neonatal death: The death of a live born infant after 7 completed days, but before 28 
completed days after birth.  
Neonatal Death: The death of a baby that occur at less than 28 days of age. 
Parity - refers to delivery that occurs after viability of the pregnancy, usually after 28 
weeks.          
Perinatal death: Perinatal deaths comprises the sum of all still births and early neonatal 
death 
Placenta accreta: refers to the clinical condition in which any part of the placenta invades 
and is inseparable from the uterine wall (ACOG, 2014). 
 Placenta previa: is a condition where the placenta lies low in the uterus and partially or 
completely covers the cervix. 
Postpartum Hemorrhage (PPH): Either primary from the third stage of labour till 24 
hours after delivery or secondary started after 24 hours of delivery till one week  
postpartum. 
Pre-eclampsia : blood pressure greater than or equal to 140 mm Hg systolic or greater 
than or equal to 90 mm Hg diastolic in 2 occasions at least 4 hours apart after 20 weeks of 
gestation with proteinuria of >300 mg per  24 hours or dipstick 1+ with or without edema 
(ACOG, 2013).   
Pregnancy induced Hypertension (PIH): which diagnosed after 20 weeks of gestation. 
Pregnancy outcomes: either maternal or newborn related outcomes. 
Preterm Birth: birth of baby before 37 complete weeks of gestation.  
Preterm period: refers to less than 37 completed weeks of gestation. 
Quality of life (QOL): is the general well-being of individuals and societies which include 
physical, psychological, environmental and social relationships in addition to overall 
satisfaction. 
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Still birth: The birth of a dead fetus at 28weeks or more and birth weight equal or more 
than 500gms (WHO, 2004). 
Term period: the period from 37 completed weeks up to the end of 42nd week (ACOG, 
2014) . 
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Chapter 2: Conceptual Framework and Literature Review 
 
2.1 Conceptual framework 
The researcher drew the conceptual framework relying on literature and personal 
experience, the framework demonstrates what the researcher is going to study, it connects 
and clarifies the relationship between the dependent and independent variables.  
2.1.1. Demographic Profile:  
This domain includes some variables such as: 
Age, education level, income, livelihood and occupation. 
2.1.2 Obstetric profile 
Which consist of different variables such as: 
Gestational age which calculated by completed weeks, parity/gravidity, antenatal care 
registration and number of visits during last pregnancy, anemia, obesity and systolic and 
diastolic blood pressure mean. 
The variables of previous domains might be determinants for HTN in pregnancy and its 
adverse outcomes. The variables of demographic and obstetric profile could affect the 
pregnancy outcome through their effect (direct or indirect) on HTN in pregnancy. 
Gestational age refers to the duration of gestation. It is measured from the first day of the 
last menstrual period and is expressed by completed weeks. 
2.1.3 Hypertension in pregnancy  
HTN in Pregnancy as independent variable includes chronic hypertension and pregnancy 
induced hypertension which mean an increase of blood pressure during pregnancy.  
Chronic hypertension diagnosed before pregnancy or develops before 20 weeks gestation. 
Pregnancy induced hypertension diagnosed after 20 weeks of gestation. 
The severity of HTN could determine the presence of adverse pregnancy outcomes which 
may affect both the mother and newborn.  
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Figure 2.1: Conceptual framework 
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2.1.4 Pregnancy outcomes 
The demographic and obstetric profiles interact with HTN in pregnancy to determine the 
pregnancy outcomes which consist of two groups:   
Adverse Maternal related outcomes: (dependent variable) including the following: 
Preeclampsia/eclampsia, antepartum hemorrhage, postpartum hemorrhage, HELLP 
syndrome, abruptio placenta, mode of delivery (CS) and recovery from HTN. 
Quality of life dependent variable to measure if the quality of life affected or not by 
presence of HTN in the last pregnancy. 
Adverse Newborn related outcomes: The new newborn related outcome (dependent) is 
including the following: Preterm birth, LBW, Neonatal admissions, Stillbirth and neonatal 
death.  
 
2.2. Literature review 
2.2.1. Hypertension 
HTN is a major and important public health problem worldwide and a risk factor for 
development of the most common cardiovascular diseases (CVDs). By 2030, the estimated 
23 million cardiovascular deaths are expected to have HTN, about 85% of them occurring 
in low and middle-income countries (WHO, 1987). 
In Gaza Strip, the prevalence of HTN was 19.1% in 2014 (UNRWA, 2015). And in Saudi 
Arabia the prevalence was 26.1% (Al-Nozha et al., 2007). But, in the United States the 
prevalence of hypertension for 2011–2014 among adults was 29.0% and was among men 
(30.0%) and women (28.1%), this prevalence was increased with age and men had a higher 
prevalence of hypertension (Yoon et al., 2015).  
The lowest prevalence among the above mentioned studies, is observed in Gaza Strip that’s 
I think it might be due to UNRWA that targeted only accessible refugee population.  
In Pakistan, a cross sectional study conducted in medical department, Combined Military 
Hospital Okara, during the period from August to December 2012, indicates that the mean 
systolic blood pressure of study group was 118 mm Hg + 10.431 and mean diastolic blood 
pressure was 81 mmHg + 9.522. About 217 soldiers (9.8%) were found to be hypertensive, 
4.4% were normal weight hypertensive whereas frequency of hypertension among over 
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weight individuals was 8.9% and among obese population was 15.1 % (Kamran et al., 
2016). I think the prevalence of HTN was relatively low as the study was conducted among 
soldiers only and not fully maintain population representativeness. 
In Jordan, the review article of Hypertension Prevalence, Awareness, Treatment and 
Control, and Associated Factors conducted, indicates that the hypertension is a common 
and important public health problem in Jordan, and shows that among 4117 participant was 
32.2% having HTN, the prevalence rate was higher among males and the older age group 
50 years and above. The logistic regression indicates that increasing age and BMI, the 
presence of DM, and the lowest level of education were significantly associated with HTN 
(Jaddou et al., 2011). 
Hypertension refers to Systolic blood pressure equal to or greater than 140 mmHg or 
diastolic blood pressure equal to or greater than 90 mmHg, or currently taking medication 
as antihypertensive agents to lower high blood pressure. Whereas, controlled hypertension 
when Systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 
90 mmHg (Chobanian et al., 2003).  
The Joint National Committee (JNC 7) classified blood pressure into the following five 
categories: Normal blood pressure refers to systolic blood pressure less than 120 mm hg 
and diastolic blood pressure less than 80 mm hg, prehypertension when the systolic 
pressure ranged between 120 and 129 mm Hg and diastolic blood pressure between 80 and 
89 mmHg, hypertension refers to systolic blood pressure equal or more than 140 mm Hg 
and/or systolic blood pressure equal or more than 90 mm Hg, HTN stage 1 defined as 
systolic blood pressure ranged from 140 to 159 mm Hg and/or diastolic blood pressure 
from 90 to 99 mm Hg and HTN stage 2 defined as systolic blood pressure is 160 mm Hg or 
more and/or diastolic blood pressure is 100 mm Hg or more. There is a continuous 
relationship between BP and risk of CVD events. The chance of developing of heart attack, 
heart failure, stroke, and kidney diseases is greater with higher blood pressure (Chobanian 
et al., 2003). 
UNRWA, health Department classifies the HTN in adult over the age of 18 into the 
following categories: Optimal blood pressure (systolic blood pressure <120 mm Hg) and 
(diastolic blood pressure <80 mm Hg), prehypertension (systolic blood pressure 120-139 
mm Hg) and (diastolic blood pressure 80-90 mm Hg), HTN (systolic blood pressure ≥140 
mm Hg) and/or (diastolic blood pressure ≥90 mm Hg), HTN grade-1(systolic blood 
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pressure 140-159 mm Hg) and/or (diastolic blood pressure 90-99 mm Hg), HTN grade-
2(systolic blood pressure 160-179 mm Hg) and/or (diastolic blood pressure 100-109 mm 
Hg) and HTN grade-2(systolic blood pressure ≥180 mm Hg) and/or (diastolic blood 
pressure ≥110 mm Hg). 
In summary, the HTN refers to systolic equal or more than 140 mmHg and/or diastolic 
blood pressure 9o mmHg. And could be among the main risk factors for development of 
CVD, DM, kidney diseases, CVA and other morbidities in addition to the mortality. 
Moreover, HTN can impaired the life quality. 
2.2.2. Hypertension in Pregnancy  
The hypertensive disorders of pregnancy are a major health problem worldwide (WHO, 
1987). Pregnancy induced hypertension (PIH) is a common health problem with adverse 
outcomes for both mother and fetus/neonate. It is could be a multifactorial health condition 
(Kintiraki et al., 2015). In Zambia The prevalence rate of hypertensive disorders of 
pregnancy was 17.7% among women admitted to tertiary hospital (Shaba & Siziya, 2015). 
Whereas, in Zimbabwe, the prevalence of pregnancy induced hypertension was higher as 
19.2% among women seeking maternity services (Muti et al., 2014). But, in India, it was 
7.3% (Manjusha Sajith et al., 2014). 
From the previous studies were noted a high prevalence of HTN in pregnancy which 
affects the pregnancy outcomes.  
Definition and Classification  
In literature, the hypertension in pregnancy is defined differently. Hypertension in 
pregnancy should be defined as a diastolic blood pressure of 90 mm Hg or more (Helewa 
et al., 1997). UNRWA (2009) defined the hypertension in pregnancy by an absolute level 
of blood pressure (140/90mmHg or greater) or by an increase in blood pressure from pre-
conception or from first trimester levels as systolic blood pressure rise by 25mmHg or 
greater and diastolic blood pressure rise by 15mmHg or more. In summary, some literature 
used Hypertensive Disorders in Pregnancy, and in others we could see a Hypertension in 
pregnancy or Pregnancy Hypertension. Moreover, we could also face pregnancy induced 
Hypertension. All of which to some extent used to describe different types of Hypertension 
during pregnancy. 
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In literature we found different classifications, the researcher demonstrated some of them 
for better understanding. According to WHO, the hypertensive and proteinuric disorders 
that occur during pregnancy were classified into: Gestational hypertension refers to HTN 
without proteinuria after 20 weeks of gestation and/or during labor and/or within 48 hours 
after delivery, unclassified hypertension during pregnancy refers to HTN found when 
blood pressure is recorded as first time after 20 weeks of gestation and/or during labor 
and/or within 48 hours of delivery, gestational proteinuria refers to development of 
proteinuria (equal to or greater than 0.3 g/l) after 20 weeks of gestation and/or during labor 
and/or within 48 hours after delivery, Pre-eclampsia refers to development of Gestational 
HTN and proteinuria after 20 weeks of gestation and/or during labor and/or within 48 
hours after delivery, eclampsia: Antepartum, intrapartum and postpartum, Underlying 
hypertension or renal disease, pre-existing HTN or renal HTN and/or proteinuria during 
pregnancy and superimposed Pre-eclampsia/Eclampsia (WHO, 1987).  
However, The Canadian Hypertension Society (1997) classified Hypertensive disorder of 
pregnancy into: Pre-existing hypertension that diagnosed before pregnancy or within 20 
weeks’ of gestation, gestational hypertension which develops after 20 weeks’ gestation, 
pre-existing hypertension and superimposed gestational hypertension with proteinuria and 
unclassifiable antenatally. But, The American College of Obstetricians and Gynecologists 
(ACOG, 2013) classifies hypertensive disorders of pregnancy into four categories: 
Preeclampsia-eclampsia (elevation of blood pressure after 20 weeks of gestation with 
proteinuria or any of the severe forms of preeclampsia), chronic hypertension: refers to 
HTN before pregnancy (of any cause that predates pregnancy), chronic hypertension with 
superimposed preeclampsia and gestational hypertension elevation of blood pressure after 
20 weeks of gestation without proteinuria or any of the severe forms of preeclampsia.  
On the other hand, the UNRWA (2009) classified HTN in pregnancy into: Chronic - pre-
existing before pregnancy with incidence ranged between 1-5% of all pregnancies and is 
more prevalent among older and /or obese women, pre-eclampsia or pregnancy-induced 
hypertension (refers to an increase in blood pressure which might be with proteinuria, 
edema or both after 20 weeks of gestation) It occurs mostly among primigravidas with 
incidence ranged between 2-7% and is increased with increased placental mass and with 
possible progression to eclampsia and pre-eclampsia superimposed on chronic 
hypertension (UNRWA, 2009).  
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My point of view, UNRWA classification is easier and more practical for GG than other 
classifications due to a limited resources. 
In Sudan, a prospective observational hospital based study, conducted in the neonatal 
intensive care unit at Soba University Hospital in Khartoum, during the period from 
October 2011 to July 2012. Aimed to determine the neonatal outcome in hypertensive 
disorders of pregnancy, shows that out of 3168 deliveries sixty nine deliveries were found 
to be complicated by hypertensive disorders of pregnancy, which gives a prevalence of 
2.17%. Of these, (42%) were pregnancy induced hypertension while (21.7%) and (4.3%) 
had preeclampsia and eclampsia respectively. Chronic hypertension was diagnosed in (20.2 
%). Patients who had chronic hypertension with superimposed preeclampsia were (11.5%) 
of cases. The incidence of hypertension was higher among pregnant women aged 26-
30years (36.2 %) and 31-35 years (28.9%). About 58% of the hypertensive women were 
multiparous. 68 (98.5 %) were delivered by caesarean section, (43%) of them were carried 
out as an emergency procedure (Kheir et al., 2014). 
While, a hospital-based prospective cohort study conducted in Saudi Arabia in tree hospital 
with sample size 14000 women to explore the impact of maternal age on pregnancy 
outcomes, found that advanced maternal age is associated with increased risk of preterm 
delivery, CS and gestational diabetes and adolescents mother are at increased risk of 
preterm delivery and more likely to have vaginal delivery (Fayed et al., 2017). A 
population-based retrospective study on 2000 national health survey in Oman to study the 
advanced maternal age and pregnancy outcomes, the researcher found that the mothers 
aged ≥35 years were at increased risks of spontaneous abortion, preeclampsia, cesarean 
section delivery, prolonged labor, and gestational diabetes compared with adult mothers 
aged 20–34 years (Bakheit, 2015). A cross-sectional study conducted in Accra among 
mothers in maternity unit, indicated that was a statistical relationship (p<0.001) between 
age and adverse pregnancy outcomes (Adu-Bonsaffo, 2014). Regarding obesity the 
prevalence of overweight and obesity among school children ranged from 7% to 45%. And 
among adults from 25% to 81.9% (Musaiger, 2011).  
However, El Kishawi et al. (2014) found that obesity and overweight are highly prevalent 
among women in urban area (57.0%), refugee camp (66.8%), and rural area (67.5%) in 
Gaza Strip. Also, BMI increased with age, adjusted b = 0.39; 95% CI (0.31, 0.48); 
p≤0.001, BMI was lower in low-income participants, adjusted b = −1.59, 95% CI (2.74,-
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0.44),p = 0.007 and housewives were more susceptible to obesity than employed woman, 
adjusted b = −2.76, 95% CI (5.33,-0.19), p=0.036. 
The previous studies showed that the HTN in pregnancy can cause a several adverse 
pregnancy outcomes for the mother and new born. 
2.2.3. Pregnancy outcomes  
2.2.3.1. Adverse maternal outcome 
In Bangladesh, a prospective study was done at Ad-din Medical College and Hospital 
during the period from January to June 2012 at the department of Obstetrics and 
Gynecology to observe the perinatal outcome of neonates with maternal hypertensive 
disorders in pregnancy. 73 mothers with their babies were included for the study. Thirty 
five mothers (47.9%) had regular antenatal checkup (ANC, where 38 (52%) had irregular. 
Primipara were (26%) and (74%) were multipara, (60%) had positive family history or had 
own history of hypertensive disorder during their previous pregnancy. (17.8%) had normal 
vaginal delivery, (82.19%) had lower uterine cesarean section. 30 babies (41%) were 
admitted. 44 mothers (60%) had gestational hypertension, 21 had (28.6%) pre-eclamtic 
toxemia, 3 had (4.1%) eclampsia, 5 had (6.8%) essential hypertension 3 of them 
subsequently developed PET. Mean maternal age 26.86 years, gestational age 34.15 
(±1.46)weeks among admitted and 36.30 (±1.6) weeks among non-admitted. Mean birth 
weight was 1.69 (±0.39) kg. among admitted and 2.71 (±0.31) kg. in non-admitted group. 
In addition 5 intra uterine death observed in single pregnancy (Hassan, 2013). 
Preeclampsia/Eclampsia  
Pregnant women with preeclampsia may have any of the following complication: 
uncontrollable severe hypertension, eclampsia, pulmonary edema, disseminated 
intravascular coagulation, abruption placentae in addition to other complications (ACOG, 
2013).  
The ACOG refers severe features preeclampsia to any of the following conditions: 
Hypertension (diastolic >110 or systolic >160 on two occasions at least 4 hours apart on 
bed rest position), thrombocytopenia (when platelet count <100,000), impaired liver 
function (elevation of blood levels of liver transaminases is twice of the normal, severe 
epigastric pain or persistent right upper quadrant pain), new development of renal 
insufficiency, pulmonary edema and onset of new cerebral or visual disturbances (ibid).  
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The incidences of pre-eclampsia and eclampsia are deferent between and within regions, 
the highest values for pre-eclampsia and eclampsia observed in the American and African 
regions, respectively. Pre-eclampsia is showing the greatest disparities, the incidence 
ranged from 0.20% in Vietnam to 6.71% in Mongolia. According to income, the highest 
incidences of pre-eclampsia were observed in upper middle income countries, however the 
eclampsia appeared to be more frequent in lower middle income countries (Abalos et al., 
2014).  
A prospective study conducted for one year period in India among 1330 inpatients at 
Gynecology and Obstetrics Department at Bharati Hospital, Pune. The results indicates 
that the prevalence of Hypertensive Disorders of Pregnancy was 7.8%, of them 71.2% with 
preeclampsia, 19.2% with gestational hypertension, 7.7% with eclampsia and 1.9% with 
chronic hypertension. This incidence was higher among primigravidae (53.8%) and The 
most commonly prescribed antihypertensive drugs was Methyl dopa (17.3 %) (Sajith et al., 
2014). I think the prevalence of preeclampsia in this study was high as all pregnant women 
were admitted to hospital and represent more the women who at the highest risk. A study 
included a total of 21,928 women conducted in Jordan showed that the incidence rate of 
preeclampsia was 1.3%. High blood pressure (OR = 11.9) and obesity (OR = 2.6) were 
significantly associated with increasing odds of preeclampsia. The risk of preeclampsia 
was 2.3 times higher in first pregnancies than that in second or more pregnancies. The 
neonatal mortality rate (81 vs. 12 per 1000 live births), and prematurity (30.8% vs. 7%), 
and the rates of LBW delivery (32.5% vs. 8.3%)were significantly higher among women 
with preeclampsia (Khader et al., 2017). 
A prospective study of five hundred pregnant women with previous preeclampsia shows 
the women with preeclampsia with history of delivery at 37 weeks’ gestation in a previous 
pregnancy had a 1 in 4 risk (23%) of recurrent disease. women who treated by 
antihypertensive agents were at greater risk for recurrent disease. Of the women who 
experienced recurrent preeclampsia, those with history of previous delivery at 34 weeks’ 
gestation were more likely to deliver an infant with SGA (71% vs 29%; P.0001) and to 
have gestational hypertension earlier (n 34.4 (IQR, 28.2–37.1) vs 36.1 (IQR, 34.6–38.3); 
P.028). than were those women who delivered from 34-37 weeks (n 41) to develop preterm 
deliveries at 37 weeks’ gestation (n 54 (71%) vs 16 (39%); P.001) and at 34 weeks (n 31 
(41%) vs 5 (12%); P.001) (Bramham et al., 2011)..  
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A cross-sectional study conducted on behalf of the WHO Multicountry Survey on Maternal 
and Newborn Health Research Network-(WHOMCS) which implemented at 357 health 
facilities in 29 countries from Asia, Africa,, Latin America and the Middle East, shows that 
the incidence of hypertensive disorders of pregnancy was 2,7% (8542 from a total 313030 
women in database). The total figures for chronic hypertension, pre-eclampsia and 
eclampsia are 0.29%, 2.16% and 0.28% of all deliveries respectively. The most prevalent 
maternal outcomes were chronic HTN (12,06%), renal diseases (7.84%), Sepsis (5,28%), 
hepatic diseases (3.92%), Anemia (3.14%). Maternal severe outcome more prevalent with 
women with eclampsia (18.06%), women with pre-eclampsia (4.31%) and women without 
pre-eclampsia/eclampsia (0.32%). Maternal deaths were higher with women with 
eclampsia (3.66%), women with pre-eclampsia (0.43%) and women without pre-
eclampsia/eclampsia (0.05%). Noting that, all the previous results were statistically 
significant (Abalos et al., 2014).  
 I think that all the pre/eclmpsia related studies demonstrated the danger of its occurrence 
on the mother and new born and might be a life threatening. Regardless the size of 
previous study, I think some of the previous results were not fully representative as all the 
women included in the study only who accessed secondary and tertiary health centers and 
the primary health centers not included which may increase the incidence of different 
outcomes.  
Vascular adverse outcome  
A case-control study conducted to examine the relationships between hypertensive 
disorders of pregnancy and different predictive factors for vascular disease shows that 
Previous hypertensive disorders of pregnancy are a strong predictor for later vascular 
morbidity such as cerebrovascular, cardiovascular and renal hypertensive disease 
(Schokker et al.,2015). The women of hypertensive pregnancy disorders women may 
exhibit long–term worse blood pressure control and adverse left ventricular remodeling 
(Mesquita, 2014). Hypertensive disorders of pregnancy and gestational diabetes increase 
the risk of premature vascular disease (Nerenberg et al., 2014). However, In India, a study 
indicated that the retinal changes were found in 27.27% of patients with pregnancy induced 
hypertension (Bhupally et al., 2015).  
A review study conducted by Gongora & Wenger (2015) of cardiovascular complication in 
pregnancy shows that Pre-eclampsia was occurred in 3% to 5% of all pregnancies and 
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women with a history of pre-eclampsia have a four-fold higher risk of hypertension and a 
three-fold higher risk of type 2 diabetes mellitus and doubled risk of stroke, cardiac 
ischemia, or venous thrombosis within 10 to 20 years after pregnancy(Gongora & Wenger, 
2015).  
There may be a synergetic effect of both gestational hypertension and postpartum incident 
hypertension as women with both were at higher risk of cardiovascular events than were 
women with gestational or incident hypertension alone (Yeh et al., 2014).  
A retrospective study conducted in Saudi Arabia to determine the risk factors for PPH 
revealed that preeclampsia and history of APP by >6 and >8-fold respectively increased 
the risk for PPH (Al-Kadri et al., 2009). Another retrospective study showed that the APH 
prevalence was1.2% and among the common causes were abruptio placenta (68.3%) and 
placenta previa (30.0%) in Nigeria (Takai et al., 2017). Also, found that was a statistically 
significant occurrence of placental abruption among hypertensive women (p=0.00, 
RR=2.60 and OR=14.07) compared with placenta previa (Bako et al., 2008). 
In Qatar, a study conducted to determine risk factors for APH revealed that the overall 
prevalence of APH was 15.3% with 6.7% among Qatari's and 8.6% among non-Qatari 
Arab women. lower education primary or below (AOR 1.72; 95%CI 1.22-2.43), and 
intermediate education AOR 1.41; 95%CI 0.88-2.26; P=0.005) compared to university 
education was significantly associated with APH. As for maternal biological 
characteristics, family history of G6PD (AOR 1.87; 95% CI 1.18-2.95; P=0.007). Family 
history of hypertension (OR 1.78; 95%CI 1.30-2.44; P<0.001) was significant (Bener at al., 
2012).  
Bener et al. (2013) also found that women aged 35 years or older had a significantly higher 
risk of APH (17.9% vs. 13.7%; P = 0.042) than younger women. Among 8,571,209 
deliveries, 25,906 (3.0 per 1000) were complicated by severe PPH (P for yearly trend 
<.0001), significant risk factors were maternal age ≥35 years ( aOR, 1.5; 95% CI, 1.5–1.6), 
multiple pregnancy (aOR, 2.8; 95% CI, 2.6–3.0), fibroids (aOR, 2.0; 95% CI, 1.8–2.2), 
preeclampsia (aOR, 3.1; 95% CI, 2.9–3.3), amnionitis (aOR, 2.9; 95% CI, 2.5–3.4), 
placenta previa or abruption (aOR, 7.0; 95% CI, 6.6–7.3) (Michael et al. 2013). 
The etiology of placental abruption is unknown, however it most likely occurs among 
smokers, in hypertensive pregnancies, in pregnancies with intra uterine growth restriction, 
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in women with a previous placental abruption and in addition to other conditions (Bako et 
al., 2008). The placental abruption, defined as the premature separation of the placenta 
before the delivery of fetus, is among the most dangerous complications of pregnancy for 
both the fetus and mother.  
A retrospective cohort study was conducted in the United States, 1995–2002 (n 
30,378,902) using data on women that delivered singleton live births and stillbirths at 20 or 
more weeks of gestation, shows that at preterm gestation, the rates of acute-inflammation 
were higher among women with than without abruption (12.0% compared with 10.2%; RR 
1.38, 95% confidence interval [CI] 1.34–1.42). At term, acute-inflammation were present 
in 4.2% and 3.3% of births with and without abruption, respectively (RR 1.39, 95% CI 
1.33–1.45) (Ananth et al., 2006). Moreover, Bahar et al., (2009) found that the incidence of 
Placenta previa (PP) was 0.73%. Major PP 56.5% and minor PP 43.5%. women with major 
PP showed a significantly higher incidence of antepartum hemorrhage (OR 3.18; 95% CI 
1.58–6.4, P = 0.001) and placenta accreta (OR 3.2; 95% CI 1.22–8.33, P = 0.017).  
While, Senkoro et al., (2017) found that 73.3% of a women with placenta previa had a 
delivery by CS (OR 9.68; 95% CI: 6.66–14.1) and women with placenta previa had 
increased odds of APH (OR 9.21; 95% CI: 5.3–16.0) and PPH (OR 17.6; 95% CI: 8.6–
36.2) in Tanzania (Senkoro et al., 2017) 
Another comparative study also confirmed the relationship between the hypertension and 
placental abruption, the study was conducted in Pakistan and included of 50 cases and 50 
controls for placental abruption, indicates that the mean systolic blood pressure (SBP) of 
was 155±7.8 mmHg and was 120±14 mmHg among controls. Mean diastolic blood 
pressure (DBP) of the cases was 104±6.6 mmHg and 71±11mmHg. Forty-nine 5 (10%) 
controls and (98%) of the cases were hypertensive while 45 (90%) controls and 1 (2%) 
case were non-hypertensive (p=0.000) (Khattak et al., 2012). 
HELLP syndrome refers to hemolysis (H), elevated liver enzymes (EL), thrombocytopenia 
(low platelet count-LP), it is syndrome of multisystem disorder with an incidence of 0.17-
0.85% of all pregnancies associated with a severe adverse maternal and fetal prognosis. 
The most accepted hypotheses are; a change in the immune feto-maternal balance, platelet 
aggregation, endothelial dysfunction, arterial hypertension. HELLP syndrome could be 
occured due to a generalized microangiopathy, mostly among older multiparous women in 
the third trimester of pregnancy, which develops with focal liver involvement, hemolysis 
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and thrombocytopenia which may lead to hepatic rupture, cerebral hemorrhage and DIC 
complications (Mihu et al., 2007). 
I think that in some studies there was a relation with HTN in pregnancy specially for 
placental abruption than placenta previa.  
And the results of the bellow study agreed with the mentioned above study regarding the 
severity of HELLP syndrome and the adverse maternal and fetal outcomes. In Iran, a 
retrospective study was conducted to determine the maternal and neonatal outcomes in 
HELLP syndrome, partial HELLP syndrome (PHS) and pre-eclampsia, and was done on 
pregnant women admitted in the Yahyanejad Hospital in the Babol University of Medical 
Science during the period from 1998 to 2009. A total of 327 pregnant women were 
categorized into three groups, severe pre-eclampsia, HELLP syndrome and PHS. The 
findings shows that the gestational age (35.72±3.15 WK) at delivery (P<0.031) and birth 
weight (P<0.00) were lower significantly in the women of HELLP syndrome. Indication 
for caesarean section, blood transfusion, acute renal failure, need to ICU care and liver 
hematoma were significantly greater in the women with HELLP syndrome (Bouzari et al., 
2013).  
The Induction of labor was more prevalent among HELLP (64.5%), PHS (43.3%) and 
preeclampsia (40.4%). Need to ICU was higher in women with HELLP (11.8%, P<0.001). 
The same finding was observed of ARF (11.8%, P<0.001). Cesarean section: HELLP 
(23.5%, P<0.001), preeclampsia (3.4%) and PHS (3%). Abruption placenta: HELLP 
(17.6%), preeclampsia (9%) and PHS (6.4%). Blood transfusion: HELLP (23.5%, 
P<0.001) and PHS (3.4%). Pulmonary edema outcome was only present in HELLP (5.9%, 
P<0.001). Eclampcia; HELLP (5.9%) and preeclampsia (2.2%). One case of maternal 
death was observed among women with HELLP syndrome (ibid).  
2.2.3.2. Quality of life (QOL) 
It's well-known that the WHO Quality of Life-BREF instrument assess four domains, the 
first one about physical health (energy and fatigue, pain and discomfort, sleep and rest), the 
second about psychological health (bodily image and appearance, negative and positive 
feelings, self-esteem thinking, learning, memory and concentration), the third about social 
relationships (personal relationships, social support and sexual activity) and the fourth for 
environmental health (financial resources freedom, physical safety and security health and 
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social care and home environment) and all these domains are calculated in numerical 
values (WHO, 1998).  
A study conducted in Vietnam to determine the quality of life among people with HTN in 
rural area, the study has shown moderate quality of life among hypertensive patients all 
domains, except for psychological health, which was relatively low (Ha et al., 2014). 
Another study conducted in Poland shows that comorbidities and the number of 
medications are the primary factors associated with lower health-related quality of life in 
hypertensive patients women reported lower health-related quality all in dimensions 
(Zygmuntowicz et al., 2012). 
 
2.2.3.3. Newborn outcomes 
A cross-sectional study which based on WHO multi-country survey shows the following 
newborn outcomes which associated with pre-eclampsia and eclampsia: The LBW (less 
than 2500 gm) incidence of was 10.6% among women without pre-eclampsia/eclampsia, 
34.3% among women with pre-eclampsia and 44.6% among women with eclampsia. 
Stillbirth incidence was higher among women with eclampsia (15.3%), women with pre-
eclampsia (6.4%) and women without pre-eclampsia/eclampsia (1.9%).  
The incidence of Apgar score at 5 minutes less than 7 was higher among women with 
eclampsia (20.3%), women with pre-eclampsia (7.9%) and women without pre-
eclampsia/eclampsia (2.6%). The association between baby outcomes and pre-eclampsia 
and eclampsia indicated as fetal death was among women with eclampsia (15.32%), 
women with pre-eclampsia (6.36%) and women without pre-eclampsia/eclampsia (1.87%), 
early neonatal death women with eclampsia (8.61%), women with pre-eclampsia (3.04%) 
and women without pre-eclampsia/eclampsia (0.82%), perinatal death women with 
eclampsia (22.66%), women with pre-eclampsia (9.22%) and women without pre-
eclampsia/eclampsia (2.68%), preterm death women with eclampsia (39.34%), women 
with pre-eclampsia (30.89%) and women without pre-eclampsia/eclampsia (7.10%) and 
neonatal intensive care unit admissions women with eclampsia (32.02%), women with pre-
eclampsia (25.84%) and women without pre-eclampsia/eclampsia (6.24%). Neonatal 
complications (at least one) was more prevalent with women with eclampsia (25.5%), 
women with pre-eclampsia (20.6%) and women without pre-eclampsia/eclampsia (5.3%) 
(Abalos et al., 2014).  
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In Sudan, a prospective observational hospital based study, conducted in the neonatal 
intensive care unit to determine the neonatal outcome in hypertensive disorders of 
pregnancy, shows that 36 (52%) babies were classified as preterm, among pregnancy 
induced hypertension group (33.3%) followed by preeclampsia and chronic hypertension 
with superimposed preeclampsia groups (27.7%. 19.4% respectively) compared to chronic 
hypertension and eclampsia. the rate of SGA was higher in pre-eclampsia (53%) and 
chronic hypertension with superimposed preeclampsia compared to other groups. LGA 
was only observed in chronic hypertension (CH) (7.14%), six babies (8.6%) had birth 
asphyxia (Kheir et al., 2014).  
Most of the babies with LBW were found in the PIH group, where, babies with VLBW 
were found in the preeclampsia group and there was significant correlation between the 
birth weight and type of hypertensive disorder in pregnancy (P= 0.01). 38% of the babies 
in this group developed sepsis during their admission to the neonatal unit. Most of the 
septic babies were in the preeclampsia and chronic hypertension with superimposed 
preeclampsia groups. Thrombocytopenia was diagnosed in 14 babies (20%), which more 
found in the pre-eclampsia and chronic hypertension with superimposed pre-eclampsia 
groups. Only 4 (6 %) babies died, all within 7 days of delivery. Perinatal death occurred in 
two babies of the preeclampsia group; one baby in the one in the PIH group and chronic 
hypertension with superimposed preeclampsia (ibid).  
A hospital based case-control conducted in Gaza strip to assess the risk factors associated 
with preterm birth which included 200 cases who delivered in the hospitals during (March 
to mid April 2002) and 200 controls indicates some risk factors, among of these was 
maternal age 35 years or more which considered as statistically significant by logistic 
regression analysis (OR 1.8, 95% CI: 1–3, P = 0.04) with positive relationship. This 
maternal age is well known linked to the occurrence of medical complications of 
pregnancy such as pregnancy-induced hypertension and renal diseases that increase the 
risk of preterm birth (Abu Hamad et al., 2007).  
However, the Study of increasing neonatal mortality among Palestine Refugees in the Gaza 
Strip indicates that the infant mortality in 2013 was 22.4 per 1000 live births compared 
with 20.2 in 2008 (p = 0.61), and this change reflected an increase in neonatal mortality 
(from 12.0 to 20.3 per 1000 live births, p = 0.01). The main causes of infant deaths were 
preterm birth (39%), congenital anomalies (29%), and infections (19%). Among the factors 
related to preterm birth was a women previously classified as alert or high risk in 
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pregnancy (van den Berg, et al., 2015). Of course, it is well known that HTN in pregnancy 
is linked to preterm birth, in addition to other factors. However, other center-based cross 
sectional study was conducted in Egypt to detect the percentage and factors affecting 
preterm birth in El-Moneera general hospital in south Cairo, during the period from July to 
December 2014, the Results detected that only (8.2%) were preterm births among all 
deliveries. In addition to other factors the affection with HTN, was higher among preterm 
labor mothers as 43.9% comparing with 18.3% of full-term mothers (Abdelhady & 
Abdelwahid, 2015). 
The previous studies from different countries showed the effect of HTN in pregnancy on 
the newborn health and can cause adverse outcomes.  
 In Switzerland, a study conducted with aim to identify biomarkers for recognition of 
women at high risk of developing preeclampsia and to describe the epidemiological 
characteristics of preeclampsia. The study was based on pregnancy follow up and 
monitoring of 1571 pregnancies starting at the end of the first trimester during the period 
from July 2008 and January 2011. The findings indicates that the preeclampsia incidence 
of 2.31%, About 10% of all observed cases progressed to eclampsia, another 10% 
progressed to HELLP syndrome. Women with preeclampsia had significantly earlier 
delivery than women without preeclampsia. 6.67% of the pregnancies affected by 
preeclampsia showed an early onset of birth before gestational week 34. Thirty percent of 
preeclamptic women had a preterm birth (before 37 completed weeks of gestation). The 
incidence of preeclampsia was highest among nulliparous women. There was an observed 
decrease of preeclampsia incidence with increasing parity. Preeclampsia developed in 
25.93% of women with a past history of preeclampsia (Prude et al., 2015). 
 Also, it was noted that the pregnant women with preeclampsia had significantly higher 
systolic and diastolic blood pressure than pregnant women without preeclampsia. 
Moreover, the Neonates born to mothers with preeclampsia had significantly lower birth 
weight than neonates of mothers without preeclampsia. Apgar scores of babies born to 
mothers with preeclampsia were lower at 1 minute after birth but not after 5 and 10 
minutes. The intrauterine growth restriction was detected in 10% of The fetuses of 
preeclampsia patients (ibid).  
I think this study is very clear and understandable as included a different adverse 
pregnancy outcomes which may linked to HTN in pregnancy as the women suffered from 
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different types of hypertensive disorders with a vary adverse maternal and new born 
outcomes as preeclmpsia, HELLP syndrome, low Apgar score and intrauterine growth 
restriction.  
Intrauterine growth restriction (IUGR): 
Intrauterine growth restriction (IUGR) is associated with perinatal morbidity and mortality. 
IUGR is a condition when the fetus fails to achieve his growth potential. Whereas, 
antenatal small for gestational age (SGA) refers to fetus with weight <10th percentile. SGA 
and IUGR are commonly used interchangeably. IUGR identification starts with assessment 
of risk factors, and the diagnosis is made by ultrasound. The common risk factors of IUGR 
include maternal causes such as hypertension, diabetes, cardiopulmonary disease, 
malnutrition, anemia, smoking and drug use (Suhag & Berghella, 2013).  
A fetal growth restriction systemic review study indicates that chronic hypertension and 
preeclampsia are among the maternal conditions contributing for development of fetal 
growth restriction (Augusthy, 2015). While, the intrauterine growth restriction was 
detected in 10% of The fetuses of preeclampsia patients (Prude et al., 2015). Also in Iran, a 
retrospective study shows that the IUGR was greater in a women with HELLP syndrome 
(17.6%), (5,6%) among women with preeclampsia and (4.9%) among women who suffered 
from partial HELLP syndrome (Bouzari, Firoozabadi, & Hasannasab, 2013).  
In fact, that all the previous three categories considered as complications of hypertension in 
pregnancy. So, as hypertension is a one among other risk factors of IUGR, this result was 
shown in the conducted case-control study in Pakistan at the department of Pediatrics Post-
graduate medical institute Lady Reading Hospital Peshawar during the period from March 
2008 to April 2009 to study a maternal factors associated with IUGR. Small-for-gestational 
age live born babies were compared with appropriate-for-gestational age babies(the cases 
were 200 and controls were 200). The findings indicates an interaction between pregnancy 
induced hypertension and parity of mother on the outcome (IUGR) compared to grand 
multipara mothers and not had PIH, the odds of developing of an IUGR newborn for the 
mothers who primary para with PIH was 10.1 higher than control group (Muhammad et al., 
2010). . 
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Prematurity/Preterm Baby and Low Birth Weight (LBW) 
In Egypt, a study shows that the preterm births were (8.2%) among all deliveries. And the 
affection with HTN, was higher among preterm labor mothers as 43.9% comparing with 
18.3% of full-term mothers (Abdelhady & Abdelwahid, 2015).  
While, a case-control study conducted in Egypt to determine risk factors to preterm birth 
shows that extreme of reproductive age (<20y and ≥ 40y) were associated with increased 
risk of preterm birth (p <0.001) (El Beltagy et al., 2016). In Gaza Strip, the preterm birth 
(39%) was among the main causes of the neonatal mortality (23.3 per 1000 live birth) 
during 2013 (van den Berg et al., 2015).  
A prospective international multicenter cohort study, where follow up was complete for 
3184 participants from 3234 healthy nulliparous women with a singleton pregnancy to 
identify risk factors for spontaneous preterm birth (birth < 37 weeks gestation). The results 
demonstrate that having a mild hypertension (severe hypertension which requiring 
medication was excluded) has been identified as risk factor for spontaneous preterm birth 
after rupture of the membranes with an odds ratio of 9.65 (95% CI 2.5–37.1)in addition to 
other results (Dekker et al., 2012).  
WHO defined Preterm birth as all births before 37 completed weeks of gestation or fewer 
than 259 days since the first day of a woman’s last menstrual period (WHO, 2007). Based 
on gestational age Preterm birth can be further sub-divided into extremely preterm (<28 
weeks), very preterm (28 - <32 weeks) and moderate preterm (32 - <37 completed weeks 
of gestation). More than 1 in 10 babies are born preterm worldwide. Over 1 million 
children die each year due to complications related to preterm birth. Prematurity is the 
leading cause of neonatal deaths and now the second cause of death after pneumonia in 
children under the age of 5. Preterm birth occurs due to variety of reasons. Some of them 
resulted from early induction of labor or cesarean birth whether for medical or non-medical 
reasons. Most preterm births may happen spontaneously. Common causes of preterm birth 
include multiple pregnancies, infections and chronic conditions, such as diabetes and high 
blood pressure. Among the evidence based intervention to improve preterm birth is provide 
effective screening and management of pregnant women at higher risk of preterm birth 
such as multiple pregnancies, diabetes, high blood pressure, or with a history of previous 
preterm birth (WHO, 2012). 
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In summary, we can faced some different terminology in literature such as preterm baby 
which reflect the delivery of baby before 37 weeks of gestations, regardless of baby 
weight. On the other hand, others will use the term prematurity which refers to same issue 
as mentioned above. Moreover, we could find preterm birth in other literature with the 
same meaning but could be related to the mother more. All of studies conducted about this 
aspect reflected the importance of prematurity which indicates the deviation from normal 
pattern and the relation with other acute or chronic conditions such as HTN in pregnancy.   
WHO is defined the Low birth weight is as less than 2,500 g. Worldwide, more than 20 
million infants are born with low birth weight. Seventy-two percent of low birth weight 
infants in developing countries occurs in Asia and 22% in Africa. In Sudan, a prospective 
observational hospital based study shows that the most of the babies with LBW were found 
in the PIH group, where, babies with VLBW were found in the preeclampsia group and 
there was significant correlation between the birth weight and type of hypertensive 
disorder in pregnancy (P= 0.01) (Kheir et al., 2014).  
While, according to WHO multi-country survey showed that the LBW (less than 2500 gm) 
incidence of was 10.6% among women without pre-eclampsia/eclampsia, 34.3% among 
women with pre-eclampsia and 44.6% among women with eclampsia (Abalos et al., 2014). 
From the above studies it was clear the relation betwwen the HTN in pregnancy and the 
occurrence of low birth weight. 
Fetal/Newborn Death (Stillbirth, Neonatal and Perinatal) 
In Gaza Strip, during 2013 the neonatal mortality was 22.4 per 1000 live birth, among the 
main causes was preterm birth with 39% (van den Berg et al., 2015). Stillbirth, refers to 
fetal death at 20 weeks’ gestation or later, is one of the most prevalent adverse pregnancy 
outcomes in the United States which affect approximately 1 in 160 pregnancies, since 2003 
the stillbirth rate in the United States was at 6.2 stillbirths per 1000 births with stagnant 
character (MacDorman & Kirmeyer, 2009).  
Whereas, UNRWA defend the stillbirth (Born dead) as death prior to the complete 
expulsion or extraction from the mother (UNRWA, 2009). However, The World Health 
Organization (WHO) defines stillbirth as a baby born dead at 28 weeks of gestation or 
more, with a body length (35 cm or greater), or a birth weight (1000 gm or greater) (WHO, 
2004). As clear from the above mentioned stillbirth definitions, there were differences 
between them. Moreover, this may explain a high stillbirth rate in the United States.  
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 A cross-sectional study which based on WHO multi-country survey shows stillbirth 
incidence was higher among women with eclampsia (15.3%), women with pre-eclampsia 
(6.4%) and women without pre-eclampsia/eclampsia (1.9%) (Abalos et al., 2014).  
A population-based study conducted in the United States from March 2006 to September 
2008 with surveillance for all stillbirths at 20 weeks or greater, shows that the obstetric 
conditions and placental abnormalities were the most common causes of stillbirth. Among 
the obstetric conditions (29.3%; 95% CI), were hypertensive disorders (9.2%; 95% CI) and 
abruption (7.4%; 95% CI) (SCRN, 2011).  
While, another study indicates that 2.2 million stillbirths occur in the antenatal period, and 
given that around 75% of pregnant women globally attend antenatal clinics at least once, 
which need more effective intervention that among the possible causes of stillbirth was 
maternal associated medical conditions such as pregnancy induced hypertension (Lawn et 
al., 2009).  
However, in Iran, a retrospective study shows that the IUFD among women with 
preeclampsia (3.4%) was more than Partial HELLP Syndrome (PHS) (1.5%). Whereas, the 
FD was observed more in women with HELLP syndrome (17.6%, P<0.02), with 
preeclampsia (6.7%) and with PHS (5.4%) (Bouzari et al., 2013).  
In India, other study conducted to determine the causes of stillbirth during the period from 
January 2002 to December 2005, there were 96 stillbirths in 2728 deliveries, shows that the 
stillbirth rate was 35.2/1000. And 58.3% of total stillbirths were antepartum stillbirths, also 
17.7% of antepartum and 8.3% of intrapartum stillbirths were at term. About 70.8% of 
stillbirths were preterm. The most common causes among the mother medical conditions 
were hypertension and eclampsia, which together accounted for 26.8% of antepartum 
stillbirths. Moreover, abruptio placenta accounted for 21.9% of total stillbirths (Korde-
Nayak Vaishali, et al, 2008).  
However, A cross-sectional study to determine the newborn outcomes that related to 
preeclampsia and eclampsia shows that the fetal death was among women with eclampsia 
(15.32%), women with pre-eclampsia (6.36%) and women without pre-
eclampsia/eclampsia (1.87%), early neonatal death among women with eclampsia (8.61%), 
women with pre-eclampsia (3.04%) and women without pre-eclampsia/eclampsia (0.82%), 
perinatal death women with eclampsia (22.66%), women with pre-eclampsia (9.22%) and 
women without preeclampsia/eclampsia (2.68%), preterm death women with eclampsia 
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(39.34%), women with pre-eclampsia (30.89%) and women without preeclampsia and 
eclampsia (7.10%) (Abalos et al., 2014). The researcher thinks it was clear from the 
previous studies that the hypertension in pregnancy could cause stillbirth directly or 
indirectly.  
A study of defined cohort of 878,126 completed pregnancies conducted to examine the 
association between maternal chronic hypertension and the risk of congenital 
malformations shows that both treated and untreated chronic hypertension was associated 
with a significant increase in the risk of cardiac malformations (OR, 1.6; 95% CI, 1.4–1.9 
and OR, 1.5; 95% CI, 1.3–1.7, respectively) compared with normotensive controls 
(Bateman, et al., 2015). 
It was clear from the above mentioned studies the relation between the HTN in pregnancy 
and the occurrence of stillbirth and other adverse outcomes.  
Neonatal Admission 
Neonatal complications (at least one) was more prevalent with women with eclampsia 
(25.5%), women with pre-eclampsia (20.6%) and women without pre-eclampsia and 
eclampsia (5.3%) (Abalos et al., 2014). Apgar scores of babies born to mothers with 
preeclampsia were lower at 1 minute after birth but not after 5 and 10 minutes (Purde et al., 
2015).  
In Pakistan, A cross sectional descriptive study was conducted in the NICU of the military 
hospital Rawalpindi, during the period from January 2011 to May 2013, shows that the 
total number of neonates admitted to the NICU was 4201. Of these, (51.49%) were female, 
(48.30%) were male, and (0.21%) had ambiguous genitalia. Caesarean section (LSCS) in 
2514 (59.84%) and spontaneous vaginal delivery (SVD) in 1687 (41.15%). 948 (22.56%) 
died during their stay in the hospital. Preterm and low birth weight babies accounted for 
981 (23.35%), of the cases. Neonatal sepsis, at 713 (16.97%). respiratory distress 
syndrome (14.31%), neonatal jaundice (10.88%), birth asphyxia (9.54%),meconium 
aspiration syndrome (8.19%) and Intra Uterine Growth Retardation was 2.88% (Mahmud 
et al., 2016). 
 It was clear from the previous studies, the leading cause of NICU admissions was the 
Preterm and low birth weight babies (23.35%) of the cases. Also, the other results were 
related directly or indirectly to maternal acute and chronic condition which could include 
the hypertension in pregnancy in addition to other causes. 
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Chapter 3: Methodology 
 
In this chapter the researcher presents the methodology used in this study. It explains the 
study design, study population, study sample, eligibility criteria, period of the study, 
validity of study instrument, data collection, data entry and statistical analysis, ethical and 
administrative considerations. 
3.1 Study design 
The design of this study is analytical comparative design aiming to achieve the objectives 
of the study in identifying the differences between hypertensive and non-hypertensive 
groups in the maternal and newborn outcomes. This type of design can usually be 
conducted faster, practical and inexpensive, large number of participants could be included 
in the study within short time period.  
3.2. Study setting  
For more representativeness and accuracy, the study was  conducted at 6 UNRWA health 
centers distributed across the GG, the 6 health centers were selected randomly 2 from each 
area (north, middle and south). They are; Rimal, Sabra, Nusairat, D Balah, Maen and 
Khanyounis health centers. 
3.3 Study population  
The population of the study are the women who attended UNRWA health services in GG 
and consisted of two groups; the first one is the hypertensive group, from the women with 
history of hypertension in the last pregnancy and the second one is the non-hypertensive  
group (women without history of hypertension in recent pregnancy). The total number of 
women with HTN in pregnancy during 2015 was around 3850.   
3.4. Eligibility criteria  
Inclusion criteria  
Hypertensive group are; women who were diagnosed with hypertension before (chronic 
HTN) and after 20 weeks (PIH) of gestation or in the recent pregnancy. 
Non-Hypertensive group are; women without hypertension in the recent pregnancy. 
  
36 
Exclusion criteria:  
1. Any woman who don’t meet the inclusion criteria. 
2. Any women with Diabetes Mellitus or Heart disease. 
3. Who refuse to participate. 
3.5. Period of the study  
The data were collected from the health centers from the period of August 2016 to May 
2017. Data cleaning and analysis was done from June to September 2017.  
From October till December thesis writing. 
3.6. Sample size and sampling process  
In this study, the Raosoft, power and sample size calculations (soft program) was used in 
order to calculate the required sample and the result indicates that the representative 
sample should be at least 175 participants for each group with total of 350 participants and 
based on 1:1 ratio (Annex 2). The researcher used the following parameters for sample 
calculation; maximum acceptable percentage points of error (confidence interval 5%) with 
confidence level 95% and Power 80%. 
Also, for more representativeness, and to increase statistical power, the researcher 
increased the sample size to 430 participants, 215 participants for hypertensive group and 
215 for non-hypertensive group. Generally, Gaza Strip’s population is relatively 
considered homogeneous community with low disparities so the researcher decided to use 
stratified proportional sampling by randomly selecting six health centers after exclusion of 
some health centers where the e.Health is newly or not implemented (Jabalia, Rafah, 
Talsultan, Maghazi and etc.) at the time of proposal writing.  
The selected health centers were as following: 
 North area (Rimal and Sabra health centers), 
 Middle area (Nuesirat and Dier balah health centers) and  
 South area (Maan and Khan-Younis health centers).  
The required numbers of participant for each health centers were determined according to 
proportionate percentage of hypertension in pregnancy (Annex 3). All eligible participants 
were enrolled in the study by quota sampling during the postnatal care after obtaining 
consent form and the hypertensive and non-hypertensive groups matched by location.  
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3.7. Study instruments  
The researcher used structured questionnaire which contains  personal data, socio-
demographic characteristics (mother age at last age, marital age, income, education and 
other variables), medical history (presence of HTN or any other medical condition), 
obstetric profile which included antenatal care registration, visits, anemia, obesity and 
blood pressure mean) and birth history, and outcomes of the last pregnancy which include 
adverse maternal outcome (type of delivery, preeclampsia, antepartum and postpartum 
hemorrhage), quality of life and newborn outcome (birth weight, prematurity and other 
variables).  
In addition, WHOQOL-BREF scale with SF-26 was used which consisted of 4 domains 
(physical activity, psychological, social relationship and environmental) with overall 
satisfaction mean was used to assess the quality of life for respondents.  
The second step was record based abstraction sheet by reviewing mother’s and newborn’s 
e-medical files to obtain the relevant data about the mother (BMI, blood pressure, ANC 
registration and visits and other data) and new born health (weight, prematurity and other 
variables) the last pregnancy.  
3.8. Pilot study  
It was carried out on a sample of 20 mothers with HTN and 20 mothers without HTN in 
the last pregnancy to clarify the validity and reliability of the questionnaire. The pilot study 
did not  make changes in the study instrument.   
3.9. Data collection 
Data were  collected by three trained data collectors by using structured face-to-face 
questionnaire and quality of life S-26 which contains 4 domains in the selected UNRWA 
health centers at the time of postnatal care.  
The researcher trained the assistant data collectors about the aim, objectives of the study, 
the tools that used, and for questionnaire application. The time allocated for each interview 
took about 25-30 minutes.  
At the same period record based review took place by the researcher himself. 
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3.10. Validity and reliability  
3.10.1. Validity  
The researcher submitted the questionnaire to thirteen experts in field to evaluate the 
context and the components of the instrument, in order to ensure validity and relevance and 
their feedback were taken in consideration.  
Also, a pilot study  conducted before the actual data collection to examine participants’ 
response to the questionnaire and how they understand it.  
The face validity was insured by proper construction of questionnaire into parts with 
logical consequences and arrangements.  
3.10.2. Reliability  
The following measures were done to assure instruments reliability: 
1. Training of data collectors on questionnaire’s techniques to ensure standardization 
of questionnaire filling. 
2. The data entry filled in the same day of data collection, and this allowed for 
possible interventions to check the data quality or to re-fill the questionnaire when 
required. 
3. Re-entry of 5% of the data after finishing data entry were ensured correct entry 
procedure and decreased entry errors. 
3.11. Data entry and analysis 
The obtained data of appropriate questionnaire was entered and analyzed by the researcher 
himself with support of the supervisor using Statistical Package of Social Science (SPSS) 
program version 22 and according to the following steps: 
1- Reviewing of the questionnaires domains, structure and abstracted relevant data 
from the e-records. 
2- Coding of questions. 
3- Data model entry design by SPSS. 
4- Data cleaning. 
5- Descriptive, analyzed and tabulated statistics as frequency, mean and percentages 
will be calculated to compare the results between non-hypertensive and 
hypertensive groups. 
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6- Chi square used for categorical group  and t-test  (systolic and diastolic blood 
pressure, BMI, quality of life and other variables) were used and P values equal or 
less than 0.05 is considered as statistically significant to compare the results 
between the hypertensive and non-hypertensive groups. 
 
3.12. Ethical and administrative consideration  
The researcher was committed to all ethical and administrative consideration.  
An ethical approval obtained for from Helsinki Committee which is adopted by the world 
medical assembly and an official letter of approval to conduct the research was obtained 
from the Helsinki committee-Gaza. 
Academic approval was achieved from School of Public Health at Al-Quds University,  
Administrative organizational approval was asked for from Chief of Health programme in 
UNRWA-Gaza field office. 
In addition, the aim and objectives of the study were explained to all participants and 
consent form was obtained verbally before voluntary participation.  
3.13. Study Limitations 
 The study faced some limitations such as: 
1- Accessibility of the data that may be not documented. 
2- The drop out of the participants at the time of the study. 
3- The frequent cutoffs of electricity. 
4- Financial constrain.  
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Chapter 4: Results and Discussion 
 
This chapter demonstrates the results of statistical tests and analysis of data, including 
descriptive analysis that presents the demographic characteristics, obstetric profile and 
pregnancy outcomes of the study sample. The researcher used simple and advanced 
statistics including frequency, means, percentage, Chi square and t-test. Finally the 
researcher demonstrated the outcomes arising from this study and compared them with 
other studies.  
4.1. Descriptive analysis 
4.1.1. Socio-demographic characteristics of the study participants 
The study sample consisted of 430 women, 215 (50%) were suffered from hypertension 
during the last pregnancy (hypertensive) and 215 (50%) were not suffered from 
hypertension during the last pregnancy (non-hypertensive). The hypertensive group 
consisted of 153 (71.2%) of mothers with PIH and 62 (27.8%) of mothers with Chronic 
HTN (before 20 weeks of gestation). Also pregnancy outcome were 210 singletons and 5 
multiple among hypertensive mothers, while, were 209 and 6 among non-hypertensive 
respectively. Moreover, the mothers distribution by the sex of newborns were for 
hypertensive 116 males, 99 females and non-hypertensive mothers 103males and 112 
females. 
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Table 4.1: Distribution of participants by age, residency and education. 
Variable Hypertensive Non-hypertensive Total 
 No. % No. % No. % 
Age group (at last delivery) 
Mean, 28.82, 
Std = 6.850 
Mean, 26.50 
Std = 5.256 
Mean, 28.02, 
Std = 6.151 
20 years old and less 21 9.8 19 8.8 40 9.3 
21– 35 years 148 68.8 173 80.5 321 74.7 
More than 35 years 46 21.4 23 10.7 69 16.0 
Total 215 100.0 215 100.0 430 100.0 
Marital age 
Mean, 20.8, 
Std = 3.718 
Mean, 20.38, 
Std = 3.446 
Mean, 20.82, 
Std = 3.581 
18 years and less 58 27.0 61 28.4 119 27.7 
19 – 20 years 60 27.9 51 23.7 111 25.8 
21 – 24 years 70 32.6 75 34.9 145 33.7 
25 years and above 27 12.6 28 13.0 55 12.8 
Total 215 100.0 215 100.0 430 100.0 
Residence area 
City 79 36.7 76 35.3 155 36.0 
Village 48 22.3 71 33.0 119 27.7 
Camp 88 40.9 68 31.6 156 36.3 
Total 215 100.0 215 100.0 430 100.0 
Mother education 
Below secondary 56 26.0 45 20.9 101 23.5 
Secondary 79 36.7 76 35.3 155 36.0 
Diploma 14 6.5 24 11.2 38 8.8 
University and higher   66 30.7 70 32.6 136 31.6 
Total 215 100.0 215 100.0 430 100.0 
 
Table (4.1) presents the demographic characteristics of the study population, it shows that 
the majority of study population age at last delivery belonged to the age group of 21-35 
years (74%), (68.8%) were hypertensive and (80.5%) were non-hypertensive. (9.3%) of all 
participant belonged to age group 20 years and less, (9.8%) were hypertensive and (8.8%) 
were non-hypertensive. Three mothers had minimum age 17 years old among hypertensive 
group and (8.8) of hypertensive group had 40 and above, among them was the maximum 
age 44 years for one mother. The researcher described the extreme ages below 18 and 40 
and above to explain that they at higher risk to develop adverse pregnancy outcomes. The 
mean age at delivery for all mothers is 28.2 ± 6.1years, 28.8 ± 6.8 for hypertensive and 
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26.2±5 for non-hypertensive. Other study indicated that the advanced maternal age was 
associated with increased risk of preterm delivery, CS and adolescents mother are at 
increased risk of preterm delivery and more likely to have vaginal delivery (Fayed et al., 
2017).  
Also The researcher thinks that the adverse maternal and newborn outcomes will increased 
with age, older woman liable more to have complications. Moreover, it's well-known that 
in general the incidence of HTN especially PIH increase with age.  
Regarding marital age, it was noticed that (33.7%) of all mothers, (32.6%) of hypertensive 
women and (34.9%) of non-hypertensive women get married at age group of 21-24 years 
and (27.7%) of all participants, (27%) of hypertensive women and (28.4%) of non-
hypertensive women get married at age 18 years and less.  
The mean (± SD) marital age was 20.8 ± 3.5 years, hypertensive- 20.8 ± 3.7 and non-
hypertensive 20.3 ± 3, as described before, no big differences between the two groups in 
marital age. However, the mean marital age in Gaza strip was 19.9 and for Palestinian 
refugee in Jordan Lebanon were 20.3, 21.4 respectively (UNRWA, 2017). PCBS noted that 
during 2014 the mean marital for males in Palestine was 20.3, GS-20.2 and WB-20.4 
(PCBS, 2017). While, it was in Jordan 29.4 for males and 25.8 for females (DOS, 2014). 
The researcher can explain these differences by the variation in culture and economic 
status; some families thought it is better for girls to get married at younger age.  
 Table (4.1) shows that (36.3%) of all participants, (40.9%) of hypertensive group and 
(31.6%) of non-hypertensive group live in refugees camp. UNRWA-health program 
outlined that Palestinian population living in refugees camps in GG was 40.3%, (UNRWA, 
2017).  
Mothers live in cities were (36.0%) of all participants, (36.7%) of hypertensive group and 
(35.3%) of non-hypertensive group (27.7%) of all participants, (22.3%) of hypertensive 
women and (33.0%) of non-hypertensive women live in village. El Kishawi et al. (2014) 
found that obesity and overweight are highly prevalent among women in refugee camp 
(66.8%). The researcher thinks that the refugees camp environment (over- crowdedness, 
poor infrastructure, etc.) and displacement are considered as an important social 
determinants of Palestinian health (El Kishawi et al., 2014).  
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Table (4.1) also shows that regarding the mother education level, (23.5%) of mothers had 
attained below secondary schools, (36%) had attained secondary education, (8.8%) had 
attained college education while most of the mothers (31.6%) had university and higher 
education. for better understanding the education level for the mothers of first category 
below secondary (include illiterate, can read and write, elementary and preparatory 
education) it were one mother was illiterate and 20 mothers had only elementary from 
hypertensive, while 8 mothers from non-hypertensive group had elementary non-
hypertensive group education. However, PCBS outlined that the females who had 
university and higher education was 14.5% in G.G and 12.6% in WB (PCBS, 2106). The 
researcher attributes this differences between the study sample to the calculation method of 
PCBS depends on all females regardless married or not, while in this study all females 
were married.   
Table 4.2: Distribution of participants by working, income, house ownership and family 
type. 
Variable Hypertensive 
Non-
hypertensive 
Total 
 No. % No. % No. % 
Working 
Yes 19 8.8 20 9.3 39 9.1 
No 196 91.2 195 90.7 391 90.9 
Total 215 100.0 215 100.0 430 100.0 
Total monthly Income By NIS  
Less than 1000 NIS 100 46.5 100 46.5 200 46.5 
From 1000 to 2000 NIS              82 38.1 85 39.5 167 38.8 
Above 2000 NIS 33 15.3 30 14.0 63 14.7 
Total 215 100.0 215 100.0 430 100.0 
House Ownership 
Completely owned  84 39.1 97 45.1 181 42.1 
Family owned 125 58.1 107 49.8 232 54.0 
Rental 2 0.9 8 3.7 10 2.3 
Destroyed during the war 4 1.9 3 1.4 7 1.6 
Total 215 100.0 215 100.0 430 100.0 
Family Type 
Extended 64 29.8 63 29.3 127 29.5 
Nuclear 151 70.2 152 70.7 303 70.5 
Total 215 100.0 215 100.0 215 100.0 
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Table (4.2) shows that (9.1%) of respondents, (8.8%) of hypertensive and (9.3%) of non-
hypertensive are working, while, the majority of mothers (90.9%) are not working. PCBS 
reported that the unemployment rate among females in Palestine was 42.8% (PCBS, 2016). 
Unemployment in GG is very high and affects many aspects of women life especially in 
health.  
Findings Table (4.2) also shows that (46.5%) of all mothers had monthly income less than 
1000 NIs, (38.8%) had 1000-2000, and only (14.7%) had more than 2000 NIS. PCBS 
declared that the poverty among G.G population was 38.8% in 2011 (PCBS, 2016). This 
situation lead to w poor economic status in G.G, which increase the burden of diseases 
including adverse pregnancy outcomes and poor life quality.  
The findings of Table (4.2) indicates that (54.0%) of all mothers, (58.1%) of hypertensive 
mothers and (49.8%) of non-hypertensive mothers live in houses owned by the husband 
family, however, (1.6%) of all mothers houses had been destroyed during Gaza war-2014. 
2.3% of all mothers live in rented houses, this result is lower than PCBS results as 5.7% of 
families live in rented houses and 79% in owned houses either by husband or any one of 
his family in GG (PCBS, 2016).  
Table (4.2) also shows that (29.8%) of the mothers live within extended families are 
hypertensive and (29.3%) are non-hypertensive. Moreover, the table shows that (70.2%) of 
the mothers living within nuclear families are hypertensive and (70.7%) are non-
hypertensive. As shown from table there was no big differences between the two groups in 
the family type and may this variable had the same effect on the health of both groups, on 
the other hand, according to PCBS (85.7%) of families were nuclear (84.7% GG, 86.3% 
WB) and 10.2% were extended in Palestine (ibid).  
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Table 4.3: Distribution by family size, husband education and working.  
Variable Hypertensive Non-hypertensive Total 
 No. % No. % No. % 
Family Size 
Mean, 5.3209, 
SD= 2.510 
Mean, 5.097, 
SD = 1.878 
Mean, 5.209, 
SD =2.517 
3 members and less 77 35.8 49 22.8 126 29.3 
From 4 to 6 75 34.9 121 56.3 196 45.6 
7 members and more   63 29.3 45 20.9 108 25.1 
Total 215 100.0 215 100.0 430 100.0 
Husband education 
Below secondary 65 30.2 57 26.5 122 28.4 
Secondary 63 29.3 72 33.5 135 31.4 
Diploma 21 9.8 18 8.4 39 9.1 
University and higher  66 30.7 68 31.6 134 31.2 
Total 215 100.0 215 100.0 430 100.0 
Husband Working 
Yes 144 67.0 143 66.5 287 66.7 
No 71 33.0 72 33.5 143 33.3 
Total 215 100.0 215 100.0 430 100.0 
 
The results of table (4.3) shows that (25.1%) of participants, (29.3%) of hypertensive and 
(20.9%) of non-hypertensive live with families of 7 members and more. The mean (±SD) 
family size is 5.2±2.5, hypertensive 5.3±2.5 and non-hypertensive-5.09±1.8, this result is 
closed to UNRWA-Health department result as the average family size (5.6) in GG 
(UNRWA, 2016), while, PCBS declared that the average family size in GG was 5.7 
(PCBS, 2016).  
Table (4.3) also shows that (28.4 %) of all mothers husbands, (3.2%) of hypertensive (3 
can read and write, of elementary and 39 of preparatory education), (26.5%) of non-
hypertensive (two illiterate, one husband can read and write, 13 elementary and 41 
preparatory education) had below secondary education, while, (31.3) of all mothers 
husband. (30.7%) of hypertensive and (31.6%) of non-hypertensive are holder of university 
and higher education. While, (28.4%) of all husbands, (30.2%) of hypertensive group and 
57(26.5%) of non-hypertensive group had below secondary education. The results of 
PCBS was 15.7% of males are holder of university and higher education in GG (PCBS, 
2016), this differences may be explained by using a different methodology in calculating 
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the variables as PCBS calculation depends on all males and only who married as in our 
research.   
The table (4.3) also show that (33%) of all husbands, (33%) of hypertensive group husband 
and (33.5%) of non-hypertensive group were not employed, which closed to PCBS results, 
34% of males were not employed in G.G (PCBS, 2016).  
4.1.2. Obstetric profile 
The obstetric profile contains some variables related to the last pregnancy such as 
reproductive history, antenatal care and other related factors.  
Table 4.4: Distribution of study participants by gravidity, party and history of 
abortion. 
Variable Hypertensive Non-hypertensive Total 
 No. % No. % No. % 
Gravidity Mean, 4.3, SD = 3.2 Mean, 3.57, SD = 2.4 Mean, 3.9, SD = 2.87 
Primi gravida 63 29.3 42 19.5 105 24.4 
From 2 to 3 44 20.4 83 38.6 127 29.6 
From 4 to 6 57 26.6 64 29.8 121 28.1 
7 and more 51 23.7 26 12.1 77 17.9 
Total 215 100.0 215 100.0 430 100.0 
Parity Mean, 3.4, SD = 2.6 Mean, 2.7, SD = 1.9 Mean, 3.2, SD = 2.3 
Para one 75 34.9 50 23.3 125 29.1 
From 2 to 3 47 21.9 94 43.7 141 32.7 
From 4 to 6 61 28.3 58 26.9 119 27.7 
7 and more 32 14.9 13 6.0 45 10.5 
Total 215 100.0 215 100.0 430 100.0 
Past history of 
abortion 
Mean 0.87, Std = 
1.36 
Mean, 0.51, Std = 
0.99 
Mean, 0.69, Std = 
19.8 
Never 119 55.3 152 70.7 271 63.0 
Once 49 22.8 36 16.7 85 19.8 
Twice and More 47 21.9 27 12.6 74 17.2 
Total 215 100.0 215 100.0 430 100.0 
 
Table (4.4) shows that (24.4%) of the respondents, (29.3%) of hypertensive respondent and 
(19.5%) of Non-hypertensive were primi gravida., while (23.7%) of hypertensive and 
(12.1%) for Non- hypertensive had seven and more gravida. Gravidity mean for all 
respondents, hypertensive group and non-hypertensive group were 3.9±2.8, 4.3±3.2 and 
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3.5± 2.4 gravida respectively. Which means that hypertensive mothers had higher mean 
and more gravida than the non-hypertensive.  
Table (4.4) also shows that the most of mothers (32.7%), (21.9%) of hypertensive, (43.7%) 
of Non-hypertensive had from two to three parity with mean 3.4 ±2.6 and 2.79±1.9 for the 
hypertensive and non-hypertensive groups respectively. On the other hand, mothers who 
had one parity were (34.9%) of hypertensive mothers and (23.3%) of non-hypertensive. 
Also, (14.9%) of hypertensive group and (6.0%) of non-hypertensive had seven and more 
parity. It was clearly to observe that hypertensive mothers were more at the extreme 
categories, who had one and seven and more.  
Table (4.4) shows that the hypertensive mothers had at least a past history of one abortion 
more than non-hypertensive (22.8%, 16.7%) respectively. The same trend was observed 
for the mothers with history of 2 abortions or more (21.9%) of hypertensive (12.6%) of 
non-hypertensive. 6.8% of expected deliveries resulted in abortion during 2016 in GG, 
7.9% in Jordan and 4.8% in WB among Palestine refugees (UNRWA, 2016). Occurrence 
of abortion increased with advanced maternal age (≥ 35)  (Bakheit, 2015).  
The incidence of abortion was estimated to be 265 per 1000 live birth. recurrent abortion is 
associated with gravidity, consanguinity and marital age (Yassin, 2000). Also a study 
conducted in Pakistan, the researcher found that the abortion is associated with maternal 
age (p-.048) among other demographic factors (Catak et al., 2016) 
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Table 4.5: Distribution of birth interval, PCC, ANC and BMI.  
Variable Hypertensive Non-hypertensive Total 
 No. % No. % No. % 
Birth Interval by months 
Mean = 35.77, 
SD = 20.7 
Mean = 31.6, 
SD = 18.8 
Mean = 33.5, 
SD = 19.78 
Less than 24 months 47 33.6 62 37.6 109 35.7 
From 24 to 48 months 41 29.3 55 33.3 96 31.5 
More than 48 months 52 37.1 48 29.1 100 32.9 
Total 140 100.0 165 100.0 305 100.0 
Preconception care (PCC) 
Yes 43 20.0 49 22.8 92 21.4 
No 172 80.0 166 77.2 338 78.6 
Total 215 100.0 215 100.0 430 100.0 
ANC Early registration < 14 weeks 
Yes 161 74.9 151 77.3 312 72.6 
No 54 25.1 64 22.7 118 27.4 
Total 215 100.0 215 100.0 430 100.0 
ANC visits 
Mean = 8.06, 
SD = 2.577 
Mean = 6.655 
SD  = 2.232 
Mean = 7.358 
SD  = 2.509 
3 and less 7 3.2 18 8.4 25 5.8 
4 and more 208 96.7 197 91.6 381 94.2 
Total 215 100.0 215 100.0 430 100.0 
Body mass index (BMI) 
Mean = 30.7, 
SD = 5.59 
Mean = 25.8, 
SD = 4.38 
Mean = 28.28, 
SD = 5.59 
 Normal 24 14.9 84 55.6 108 34.6 
Overweight 49 30.5 46 30.5 95 30.5 
Obese  88 54.6 21 13.9 109 34.9 
Total 161 100.0 151 100.0 312* 100.0 
* 118 mothers were excluded as they registered for last pregnancy after 13 weeks of gestation. 
 
Table (4.5) shows that the mothers with birth interval less than 24 months were (37.1%) of 
all participants, 33.6% of hypertensive and (35.7%) of non-hypertensive. the Minimum 
birth interval was 10 months and observed once in each group, while, the maximum among 
hypertensive120 and non-hypertensive131months. Taking in consideration that 125 of 
mothers were excluded as they had the first para. The overall mean was 33.5, 35.7 for 
hypertensive and 31.6 for non-hypertensive, however, the UNRWA-Health department 
annual report showed that the birth mean interval and the percentage of women with birth 
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interval less than 24 months were 33.7 and 38.5% respectively in GG, 39 and 30.4 in WB, 
40.4 and 27.7% in Jordan and 42.4 and 30.4% for Palestinian refugees (UNRWA, 2016).  
A cross-sectional study conducted in Bangladesh to determine the determinants and 
consequences of short birth interval showed that mothers with birth intervals of less than 
21 months were at two-fold increased risk of adverse pregnancy outcome (AOR 2.23 95% 
CI 1.51-3.29), including neonatal mortality (AOR 2.28 95% CI 1.28-4.05), perinatal 
mortality (AOR 2.33, 95% CI 1.55-3.50) and stillbirth (AOR 2.13, 95% CI 1.28-3.53) in 
comparison with mothers who had birth intervals of 45 months or longer ( de Jonge et al., 
2014). It was clear from the table (4.5) that hypertensive mothers had lower birth interval 
less than 24 months, higher 24 months and more and higher mean in comparison with non-
hypertensive, also more than one third of mothers had an interval of less than 24 months 
which needs more efforts to minimize this percentage in order to reduce pregnancy adverse 
events. Therefore, the researcher thinks it’s a time to strengthening the provided family 
planning and preconception cars service to achieve better quality.  
Table (4.5) also shows that the mothers who received preconception care (PCC) were 
(21.4%), (20.0%) of hypertension group and (22.8%) of non-hypertensive group. However, 
as shown in the table (4.5) that the mothers who get pregnant after PCC of non-
hypertensive group was slightly higher than hypertensive despite that hypertensive mothers 
were in need for attention as they at higher risk to develop adverse pregnancy outcomes 
especially for these women with history of chronic HTN, PIH, preeclampsia/eclampsia 
and/or bad obstetric history.  
Table (4.5) shows that the mothers who registered for AC early for the last pregnancy up to 
13 weeks of gestation were (72.6%) of all participant, (74.9%) of hypertensive group and 
(77.3%) of non-hypertensive were registered, the minimum and maximum gestational age 
at registration were 4 and 34 for hypertensive and 4 and 31 week for non-hypertensive 
group respectively. However, the early registration for antenatal care was lower than 
UNRWA-health department result, it was 89.1% in G.G, 74.8% in WB and 82.3% in 
Jordan among Palestinian refugees (UNRWA, 2016). Moreover, the early registration 
among hypertensive mothers was slightly higher than non-hypertensive. The researcher 
can attribute these differences to low PCC coverage at that time, some mothers with high 
risk pregnancy desired to be followed up by private specialists or clinics and poor health 
care provider counseling. 
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Table (4.5) shows that (94.2%) of all participants with ANC visits mean 7.3, 208 (96.7%) 
of hypertensive group and (91.6%) of non-hypertensive group had 4 and more antenatal 
care visits during the last pregnancy. Moreover, the antenatal visits mean of hypertensive 
group (8.06) was higher than the mean of non-hypertensive (6.6) and this results are closed 
to UNRWA findings as the average number of antenatal visits was 6.7 and 95.2% of 
pregnant women had 4 visits and more in G.G (UNRWA, 2016), which reflects the quality 
of health services provided by UNRWA especially for the risky mothers. But there were a 
variations in ANC mean and the percentage of pregnant women who had four visits and 
more between WB (5.1, 91.5%), Lebanon (6.2, 94.2%) and Jordan (5.1, 81.5%) for 
Palestinian refugees (UNRWA, 2016).  
The average of ANC visits in WB was 4.6 during 2016 (MOH, 2017). The minimum 
number of visits was observed among hypertensive and non-hypertensive 2 and 1 
respectively, while the maximum was 15 and 13 respectively. A study conducted in Egypt 
showed that women with inadequate number of ANC visits had a 12-fold risk of a poor 
maternal outcome (post-partum hemorrhage, eclampsia, and intensive care unit admission), 
a 53-fold risk of a poor fetal outcome compared to women with an adequate number of 
antenatal visits.(El-Sayed Azzaz et. al, 2016). The researcher thinks that the ANC is very 
essential health preventive program aimed to reduce maternal and fetal mortality and 
morbidity. Therefore, the frequency of ANC visits plays a clear effect in pregnancy 
outcome, the of ANC visits mean and four visits and more of hypertensive was higher than 
non-hypertensive, and these differences are accepted as the hypertensive mothers are at 
higher risk to have adverse pregnancy outcomes. 
Table (4.5) shows that (35.1) of participants, (52.1%) of hypertensive and (18.1%) of non-
hypertensive were obese and (31.9%) of mothers, (34.0%) of hypertensive and (29.8%) 
were overweight. The researcher categorized BMI according to WHO criteria, BMI less 
than 18.5 kg/m2 means underweight, normal weight from 18.5 to 24.9 kg/m2, overweight 
from 25 to 29.9 kg/m2 and obesity from 30 kg/m2 and above. 118 mothers from both 
group were excluded as they registered for last pregnancy after 13 week of gestation. The 
previous findings indicate that the incidence of overweigh and obesity was higher among 
hypertensive group and the same picture was observed in the differences between the BMI 
mean of Hypertensive (30) and non-hypertensive (25). The minimum and maximum BMI 
were 19.1and 47.7 respectively among hypertensive and 18.7 and 41.3 among non-
hypertensive group. The table shows clearly that the percentage of hypertensive mothers 
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who had obesity and overweight were 54.6% and 30.5% respectively, while 13.9% and 
30.5% of non-hypertensive mothers and 34.9% and 30.5% of all mothers. The estimated 
prevalence of obesity and overweight among females was 30.8% and 60.7% Palestinian 
territory, 16% and 37% in Lebanon, 49.8% and 79.5% in Kuwait, 36.4% and 66% in 
Jordan and 41.6% and 66% in Egypt (EMRO, 2012). However, according to UNRWA 
annual report the percentage of obesity among patients with non-communicable diseases 
was 37.1% in Gaza strip, 42.1% in WB and 46.9% in Jordan for Palestinian refugees 
(UNRWA, 2016).  
The researcher thinks that the obesity and overweight are common among the Palestinian 
people and associated with other risk factors as sedentary lifestyle, age, gender and eating 
habits, thereafter, the obesity and overweight are risk factor to many lifestyle related 
illnesses including HTN which can cause maternal and newborn adverse outcomes. The 
researcher can attribute high percentage of obesity among hypertensive mothers to their 
effect on BP and to cause HTN which is very risky during pregnancy. 
 
Table 4.6: Deference's between study groups by mean of hemoglobin, systolic and 
diastolic blood pressure and postnatal care.  
Variable   No. Mean Std 
Haemoglobin 
Hypertensive 215 10.8 0.8 
Non-Hypertensive 215 10.9 0.9 
Systolic blood pressure (SBP) 
Hypertensive 215 122.1 8.2 
Non-Hypertensive 215 106.7 4.9 
Diastolic blood pressure DBP 
Hypertensive 215 81.3 5.9 
Non-Hypertensive 215 68.8 4.7 
Postnatal care Attendance in 
days 
Hypertensive 215 9.20 4.912 
Non-Hypertensive 215 7.86 3.855 
 
The table (4.6) shows that hemoglobin mean among hypertensive mothers (10.8) was 
slightly lower than non-hypertensive (10.9), the minimum hemoglobin mean was observed 
among hypertensive 8.1 and 6.7, the maximum was 13.7 among hypertensive and 13.0 
non-hypertensive. UNRWA-health department defined anemia when hemoglobin lower 
than 11gm/dl and classified into mild 10 to 10.9, moderate 7 to 9.9 and severe < 7. Anemia 
incidence in WB was 28.2%, of which mid anemia is 26.6%, moderate 1.5% and severe 
0.1% during 2016 (MOH, 2017), while, UNRWA health report showed that the prevalence 
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of anemia among pregnant women in GG was 35.6% and in WB 29.2% (UNRWA, 2017). 
Anemia is a serious complication for a women during pregnancy, its might be due to 
hemoconcetration, placentation, increased demand, inadequate intake and bleeding 
condition like APH and PPH, in addition to used medication which affect absorption of 
iron and vitamins. The researcher explained the mild difference between the two groups in 
hemoglobin mean by high prevalence of anemia among pregnant women regardless that 
the most of cases were mild which considered as public health problem. 
Table (4.6) also shows that the systolic BP mean was 122.1 among hypertensive and 106.7 
among hypertensive. While, the diastolic was 81.3, 68.8 respectively. As shown from the 
table that both systolic and diastolic BP mean were higher among hypertensive compared 
to the non-hypertensive mothers. The minimum and maximum mean were 95.2 and 146.6 
among hypertensive mothers and 88.2, 120 among non-hypertensive respectively. The 
researcher thinks that this differences in BP is related to HTN in pregnancy in association 
with diet and lifestyle which caused raised and uncontrolled BP (≥ 140 and/or ≥ 90) which 
put the mothers at higher risk of having adverse maternal and newborns outcomes. 
However, the estimated prevalence of raised BP among adult females in Palestine was 
35.6%, in Jordan 25.9%, in Lebanon 12.9% and in Egypt 40.8% (EMRO, 2012).  
Table (4.6) also shows that the postnatal care attendance in days mean was higher among 
hypertensive group (9.2) compared to non-hypertensive (7.8), which reflect a delay in 
receiving postnatal care for the hypertensive group.  
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Recovery rate from pregnancy-induced-hypertension. 
 
 
Figure 4.1: Recovery from hypertension during pregnancy 
Figure (4.1) shows that (79.1%) of the diagnosed mothers with PIH were recovered at the 
end of postnatal period (42 days after delivery) while (20.9%) were not recovered. 
Knowing that, there are 62 cases with chronic hypertension and 215 without hypertension.  
  
Recovered, 79.1 
Not recovered, 
20.9 
54 
4.1.3 Newborn outcome 
Table 4.7: Distribution of Newborns by stillbirth, birth weight, preterm birth, 
neonatal admission to hospital and death.  
Variable 
Hypertensive Non-hypertensive Total 
No. % No. % Nu. % 
Stillbirth  
Alive 213 99.1 215 100.0 428 99.5 
Stillbirth 2 0.9 0 0.0 2 0.5 
Total 215 100.0 215 100.0 430 100.0 
Birth Weight 
Mean = 3041.6  
Sd = 587.6 
Mean = 3404.4  
Sd = 456.9 
Mean = 
3223.02 Sd = 
556.2 
Normal Birth Wight 
(NBW) 
180 85.7 185 88.5 365 87.2 
Low Birth Wight 
(LBW) 
21 10.0 6 2.9 27 6.4 
High Birth Wight 
(HBW) 
9 4.3 18 8.6 27 6.4 
Total 210 100.0 209 100.0 419* 100.0 
Preterm Birth 
Yes 32 15.4 16 7.6 48 11.5 
No 176 84.6 193 92.4 369 88.5 
Total 208 100.0 209 100.0 417** 100.0 
Neonatal Admission to Hospital 
Yes 26 12.5 14 6.7 40 9.6 
No 182 87.5 195 93.3 377 90.4 
Total 208 100.0 209 100.0 417 100.0 
Neonatal death 
Yes 6 2.8 1 0.5 7 1.6 
No 207 97.2 214 99.5 423 98.4 
Total 213*** 100.0 215 100.0 428 100.0 
* 5 and 6 Twins were excluded from hypertensive and non-hypertensive respectively  
**2 Stillbirths and 5 twins were excluded from hypertensive and 5 twins from non-hypertensive 
*** 2 SB were excluded 
 
Table (4.7) shows that the total live birth was (99.5%) and stillbirths (0.9%) of 
hypertensive, where no stillbirth among non-hypertensive group. The two cases of stillbirth 
were preterm (<37 week of gestation).  
Other study showed that the incidence of stillbirth was 13 in Jordan, 9 in Iraq, 8 in Saudi 
Arabia and 13 per 1000 in Egypt in 2013 (WHO, 2013). However, stillbirth is one of the 
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most prevalent adverse pregnancy outcomes in the United States which affect 
approximately 1 in 160 pregnancies, since 2003 the stillbirth rate was at 6.2 stillbirths per 
1000 births with stagnant character (MacDorman & Kirmeyer, 2009). Many study 
conducted regarding stillbirth as a cross-sectional study showed that the fetal death was 
among women with eclampsia (15.32%), women with pre-eclampsia (6.36%) and women 
without pre-eclampsia/eclampsia (1.87%) (Abalos et al., 2014).  
Regarding the birth weight, globally, low birth weight is considered as a significant 
problem and associated with a long and short consequences. WHO defined low Birth 
weight as less than 2500 g (WHO, 2014). Table (4.7) shows that 27 (6.4%) of all 
newborns, 21 (10.0%) of hypertensive and 6 (2.9%) of non-hypertensive group had a low 
Birth weight (< 2500 g). 365 (87.2%) of newborns were with normal birth weight (NBW) 
2500-3999 g and 9 (6.4%) with high birth weight (HBW) 4000 g and more. The minimum 
birth weight was 850 g among hypertensive, on the other hand the maximum was 4500 g 
among non-hypertensive. Birth weight mean was 3223 g, hypertensive 3041.6 and non-
hypertensive 3404.4. Muti et al. (2015) found that women with PIH were more likely three 
times to deliver a low birth weight baby (OR 3.0, p = 0.0115) in Zimbabwe.  
Table (4.7) shows that (88.5 %) of mothers had term birth and (11.5%) of mothers preterm 
birth. (11.5%) of hypertensive and (7.6%) of non-hypertensive had preterm birth. The 
twins and stillbirth (13) were excluded from calculation. It is clearly that the percentage of 
preterm birth among hypertensive mother was higher than non-hypertensive..  
WHO defined Preterm birth as all births before 37 completed weeks of gestation or fewer 
than 259 days since the first day of a woman’s last menstrual period (WHO, 2007). More 
than 1 in 10 babies are born preterm worldwide. Over 1 million children die each year due 
to complications related to preterm birth. Preterm birth occurs due to variety of reasons. 
Common causes of preterm birth include multiple pregnancies, infections and chronic 
conditions, such as diabetes and high blood pressure (WHO, 2012). The main causes of 
infant deaths were preterm birth (39%), congenital anomalies ( 29%), and infections 
(19%). Among the factors related to preterm birth was a women previously classified as 
alert or high risk in pregnancy in the Gaza Strip (van den Berg et al., 2015).  
Table (4.7) shows that neonatal admission to hospitals is found in 9.6% in study sample 
with 12.5% in hypertensive group and 6.7% in non-hypertensive group. Two newborns 
were excluded as they stillbirth.  
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Also the table (4.7) shows that  (1.6%) of newborns,  (2.8%) of hypertensive and  (0.5%) 
of non-hypertensive group, where died within the first 28 days of life ( 2 stillbirths were 
excluded). All 7 deaths occurred at hospital between the first and fourteenth day of life, the 
main causes of death were prematurity and respiratory distress.  
4.1.4 Maternal outcomes 
Table 4.8: Mode of delivery among hypertensive and non-hypertensive groups. 
Variable 
Hypertensive Non-hypertensive Total 
No. % No. % No. % 
Mode of delivery 
Spontaneous normal 
vaginal delivery (SNVD)  
77 35.9 162 75.3 239 55.6 
Cesarean section (CS) 80 37.2 35 16.3 115 26.7 
Induction 58 26.9 18 8.4 76 17.7 
Total 215 100.0 215 100.0 430 100.0 
 
Table (4.8) shows that SNVD was more common among study sample (55.6%) and non-
Hypertensive (75.3%) was higher than hypertensive (35.9%). While, CS delivery was more 
common among hypertensive mothers ( 37.2%) compared with non-hypertensive (16.3%) 
and 26.7% of all mothers. Also the assisted delivery was 17.7% among all mothers and 
higher in the hypertensive (26.9%) in comparison with non-hypertensive ( 8.4%). In other 
words pregnancy termination consisted of both CS and assisted delivery (induction) was 
higher among hypertensive (64.1%) compared with non-hypertensive (24.7%). The main 
first four causes for pregnancy termination among hypertensive mothers were 
preeclampsia/eclampsia (28.3%), APH (17.4%), deterioration of fetal status (17.1%) and 
previous of scar (16%) respectively. While, previous scar (39%), poor labor progress 
(22.2%), APH (11.3%) and deterioration of fetal status (9.4%) among non-hypertensive.  
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4.1.5 Quality of life 
Table 4.9: Differences in quality of life between mothers with HTN and without HTN. 
  No. Mean Std 
Physical Activity (Domain 1) 
Hypertensive 215 66.6 17.4 
Non-Hypertensive 215 74.4 15.1 
Psychological (Domain 2) 
Hypertensive 215 64.3 12.6 
Non-Hypertensive 215 73.9 17.5 
Social Relationships (Domain 3) 
Hypertensive 212 70.5 12.9 
Non-Hypertensive 213 76.7 12.9 
Environment (Domain 4) 
Hypertensive 215 55.1 11.6 
Non-Hypertensive 215 60.1 12.2 
Overall Satisfaction 
Hypertensive 212 64.2 10.3 
Non-Hypertensive 213 71.3 10.8 
 
Table (4.9) show that the mean of physical health (66.6), psychological health (64.3), 
social relationship (70.5) and environmental health (55.1) are lower among hypertensive 
mothers compared to non-hypertensive mothers which had (74.4, 73.9, 76.7 and 60.1 
respectively). Therefore, the overall satisfaction mean across all domains (64.2) is lower 
among the mothers with HTN in last pregnancy compared to mothers without HTN (71.3). 
However, The social relationships mean (76.7) was the highest and observed among non-
hypertensive group. While, the environmental health (55.1) was the lowest among the 
hypertensive mothers. The findings of table (4.9) regarding the quality of life results 
supported the negative impact of HTN associated adverse maternal outcomes among 
women with HTN.  
4.2. Inferential analysis 
Inferential analysis was used in this study to explore differences in maternal and new born 
outcomes between the mothers with and without hypertension in the last pregnancy. 
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4.2.1 Comparison between hypertensive and non-hypertensive by socio-demographic 
characteristics. 
 
Table 4.10: Comparison between hypertensive and non-hypertensive by maternal and 
marital age.  
Variable Hypertensive Non-hypertensive Total 
χ2 Sig. 
 Mean SD Mean SD Mean SD 
Age (at last 
delivery) 
28.82 6.850 26.50 5.256 28.02 6.151 9.174 0.008 
Marital age  20.8 3.718 20.38 3.446 20.82 3.581 0.996 0.802 
Family size 5.3209 2.510 5.097 1.878 5.209 2.517 20.018 0.001 
 
Table (4.10) shows that there are a significant statistical difference in maternal age 
between hypertensive and non-hypertensive groups with (χ2 = 9.174, Sig. = 0.008). A 
study conducted in Kenya according to Jebet (2012), the maternal age is not associated 
with poor pregnancy outcomes (χ2= 7.744 p- value = <0.101). The researcher thinks that 
the previous study was conducted among mothers to determine the risk factors for poor 
pregnancy outcomes only and age was classified in a narrow range groups. While, Adu-
Bonsaffoh et al. (2014), found that was a statistical relationship between age and adverse 
pregnancy outcomes (p<0.001).  
Also, Bakheit (2015) mothers aged ≥35 years were at increased risks of spontaneous 
abortion, preeclampsia, cesarean section delivery, prolonged labor, and gestational diabetes 
compared with adult mothers aged 20–34 years. Other study indicated that the advanced 
maternal age was associated with increased risk of preterm delivery, CS and adolescents 
mother are at increased risk of preterm delivery and more likely to have vaginal delivery 
(Fayed et al., 2017). Also the study result was consistent with another study, Laxmaiah et 
al. (2015) found that the risk of hypertension was significantly (P< 0.001) increased with 
an increase of age 5.5-7.9 times higher in 35-59 year in women. However, there is no 
statistical difference between the study groups in marital age, noting that 33.7% of mothers 
get married at 21-24 years and 27.7% of them get married at age 18 years and less. The 
researcher thinks that the age is co-factor to HTN in pregnancy in occurrence of poor 
pregnancy outcome.  
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Table (4.10) shows that there is a statistical difference between hypertensive and non-
hypertensive groups in the family size (χ2 = 20.018, Sig.=0.001). Regarding groups mean, 
the hypertensive mothers had higher family size mean (5.3±2.5) compared to non-
hypertensive (5.09±1.8) which indicate that the HTN in addition to family size may 
produce poor maternal and newborn outcomes. UNRWA-Health department result as the 
average family size (5.6) in GG (UNRWA, 2016).  
This study not congruent with other study as Laxmaiah et al. (2015) who found that the 
odds ratios for hypertension were lower (0.90) among women with higher family size. The 
differences between studies related to used retrospective design and were conducted 
among all women at different ages. The researcher thinks that the increased family size 
increase the burden on mother responsibilities towards the family members and considered 
as a contributor factor in addition to presence of HTN, which affect the pregnancy 
outcomes and life quality. 
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Table 4.11: Comparison by residency area, mother education, working, total monthly 
income, house ownership and family type between the study groups. 
Variable Hypertensive 
Non-
hypertensive 
Total 
X
2 
Sig. 
 Nu. % Nu. % Nu. % 
 Residency area 
City 79 36.7 76 35.3 155 36.0 
7.068 0.028 
Village 48 22.3 71 33.0 119 27.7 
Camp 88 40.9 68 31.6 156 36.3 
Total 215 100.0 215 100.0 430 100.0 
Mother education 
Below secondary 56 26.0 45 20.9 101 23.5 
4.005 0.261 
Secondary 79 36.7 76 35.3 155 36.0 
Diploma 14 6.5 24 11.2 38 8.8 
University and higher 66 30.7 70 32.6 136 31.6 
Total 215 100.0 215 100.0 430 100.0 
Working 
Yes 19 8.8 20 9.3 39 9.1 
0.028 0.500 No 196 91.2 195 90.7 391 90.9 
Total 215 100.0 215 100.0 430 100.0 
Total monthly income  
Less than 1000 NIS 100 46.5 100 46.5 200 46.5 
0.197 0.906 
From 1001 to 2000 NIS 82 38.1 85 39.5 167 38.8 
Above 2000 NIS 33 15.3 30 14.0 63 14.7 
Total 215 100.0 215 100.0 430 100.0 
House Ownership 
Completely owned 84 39.1 97 45.1 181 42.1 
6.037 0.108 
Family owned 125 58.1 107 49.8 232 54.0 
Rented 2 0.9 8 3.7 10 2.3 
Destroyed during the war 4 1.9 3 1.4 7 1.6 
Total 215 100.0 215 100.0 430 100.0 
Family Type 
Extended 64 29.8 63 29.3 127 29.5 
0.011 0.500 Nuclear 151 70.2 152 70.7 303 70.5 
Total 215 100.0 215 100.0 215 100.0 
 
Regarding the residency area, table (4.11) shows that was a statistical differences between 
hypertensive and non-hypertensive groups (χ2 = 7.068, Sig. = 0.028). These differences 
were seen among women with HTN who live in refugees camps. UNRWA-health program 
outlined that population living in camps was 40.3% in Gaza Strip (UNRWA, 2017). The 
researcher thinks that camp population is exposed to adverse pregnancy outcomes in 
presence of HTN. 
61 
Table (4.11) shows that there are no statistical differences between the hypertensive and 
non-hypertensive groups in variables of education (χ2 = 4.005, Sig=0.261), working (χ 
0.028, Sig=0.500) and total monthly income (χ2 = 0.197, Sig=0.906). Suleiman (2014) 
conducted a prospective case-control study in Jordan on pregnant women with HTN in 
Pregnancy and found that women with low educational level at risk to have HTN in 
pregnancy. The researcher attributed the differences in results to the highest education 
level among women in GG. Moreover, PCBS (2016) outlined that the percentage females 
who had university and higher education was 14.5% in G.G and 12.6% in WB.  
Laxmaiah et al. (2015) found that the risk of hypertension was 1.2 (1.07-1.33) times higher 
among people completed education 9
th
 standard and above as compared to illiterate. The 
researcher attributed the differences regarding last study to larger population, different 
culture as conducted in India and it was a retrospective study. Our result regarding the 
study that monthly income was consistent with other study as Jebet (2012) fond that the 
total monthly income was not associated with adverse pregnancy outcome. However there 
are no significant statistical differences between study groups in their house ownership and 
family type. Laxmaiah et al. (2015) found that odds ratios for hypertension were lower 
among women residing in joint families (0.88).  
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4.2.2Obstetric profile and HTN in Pregnancy 
Table 4.12: Differences between hypertensive and hypertensive mothers in gestational 
age at registration, BMI, Hemoglobin, weight increase, systolic BP, diastolic BP, 
routine, non-routine antenatal care visit,  gravidity and parity. 
Variable  N Mean Std t Sig. 
Gestational age at 
registration (weeks) 
Hypertensive 215 10.9 5.3 -0.921 0.358 
Non-Hypertensive 215 11.4 5.6   
Body Mass Index Hypertensive 215 30.7 5.6 10.116 0.001 
Non-Hypertensive 215 25.8 4.4   
Mean haemoglobin Hypertensive 215 10.8 0.8 -0.806 0.421 
Non-Hypertensive 215 10.9 0.9   
Routine antenatal 
care visit (number) 
Hypertensive 215 8.1 2.6 6.040 0.001 
Non-Hypertensive 215 6.7 2.2   
Systolic blood 
pressure (SBP mean) 
Hypertensive 215 122.1 8.2 23.684 0.001 
Non-Hypertensive 215 106.7 4.9   
Diastolic blood 
pressure (SBP mean) 
Hypertensive 215 81.3 5.9 24.356 0.001 
Non-Hypertensive 215 68.8 4.7   
Postnatal care 
Attendance in days 
Hypertensive 215 9.20 4.912 3.146 0.002 
Non-Hypertensive 215 7.86 3.855   
 χ2 Sig. 
Gravidity 
Hypertensive 215 4.3 3.2 26.398 0.001 
Non-Hypertensive 215 3.57 2.4   
Parity 
Hypertensive 215 3.4 2.6 28.765 0.001 
Non-Hypertensive 215 2.79 1.9   
 
Table (4.12) shows that there are no statistical significant differences between the 
hypertensive mothers and non-hypertensive mothers in gestational age at registration 
(weeks) and Mean haemoglobin, while there are statistical significant differences between 
the two groups in routine antenatal care visit, mean systolic and diastolic BP, body mass 
index and postnatal care, all the differences were for Hypertensive respondents.  
Regarding routine ANC visits, table (4.12) shows that there is a significant differences 
(Sig=0.001) and hypertensive mean was higher (8.1) than non-hypertensive (6.7). 
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However, more ANC visits with presence of HTN in pregnancy may associated with 
adverse pregnancy outcomes. The researcher explains this result that a hypertensive 
mothers were a high risk pregnancy and accordingly the UNRWA healthcare providers 
asked the mothers for frequent visits for more follow up and to prevent complications. 
 Table (4.12) also shows that there is a statistical significant differences between 
Hypertensive and Non- hypertensive mothers in variable body mass index (Sig. = 0.001). 
The differences were for hypertensive mothers as they had BMI mean (30.7) higher than 
non-hypertensive (25.8). The prevalence of overweight and obesity among school children 
ranged from 7% to 45%. And among adults from 25% to 81.9% (Musaiger, 2011). 
However, a study conducted in Gaza Strip, El Kishawi et al. (2014) found that obesity and 
overweight are highly prevalent among women in urban area (57.0%), refugee camp 
(66.8%), and rural area (67.5%).This results indicates that higher BMI (obesity) in addition 
to HTN in pregnancy can produce adverse maternal and newborn outcomes. Moreover, it's 
well-known that obesity and overweight are common risk factor for development of non-
communicable diseases.  
Regarding the systolic and diastolic blood pressure, the table (4.12) shows that a 
significant differences between (Sig=0.001) the groups as SBP and DBP mean (122.1 and 
81.3) were higher than among non-hypertensive (106.7 and 68.8). The researcher thinks 
that this result is logical as mothers with HTN had a higher blood pressure. On other hand, 
blood pressure mean reflect the control status of BP during pregnancy. All these factors 
contribute to development of unwanted maternal and newborn outcomes. However, this 
result not congruent with the study of Manjusha et al. (2014) which indicted that systolic 
and diastolic BP mean were 156.6 and 101.4 respectively. This differences explained by 
that the last study was conducted among women with different type of HTN in pregnancy 
(preeclampsia/eclampsia-71%) with a prospective design. On the other hand, the estimated 
prevalence of raised BP among adult females in Palestine was 35.6%.  
Table (4.12) indicates that the postnatal care attendance in days mean higher among 
hypertensive mothers (9.2) in comparison with non-hypertensive (7.87) and this 
differences reach statistically significance (Sig=0.002). The postnatal care is very essential 
and important to be performed for all the mothers and newborn as early as possible after 
delivery, especially for the mothers with HTN in pregnancy. The researcher thinks that the 
results means that the mothers with HTN in pregnancy were attended health centers or 
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home visited for postnatal care with more days than mothers who do not had HTN, which 
put the mother and newborn at risk for development of unwanted pregnancy outcomes. 
Table (4.12) shows that there is a statistical significant differences between hypertensive 
and non- hypertensive in variable of gravidity (χ2 = 10.457, Sig. = 0.005). Gravidity mean 
among hypertensive mothers was higher than the non-hypertensive especially in the 
extreme categories primi and seven and more which might be a risk for developing adverse 
pregnancy outcomes in addition to HTN in pregnancy. This result congruent with 
retrospective cohort study conducted in Tanzania with findings that mothers with five 
gravidity and more 6 times at higher risk to have fetomaternal morbidity and mortality in 
developing countries (Elizabeth et al, 2107).  
The researcher opinion was that the gravidity first one and five and more are at higher risk 
to have adverse pregnancy outcomes especially when associated with extreme ages. In this 
line, Manjusha et al. (2014) found that the incidence of hypertension in pregnancy was 
highest among primigravidae. 
Regarding the parity, table (4.12) shows that there is a statistical significant differences 
between Hypertensive and Non- hypertensive mothers in variable of parity (χ2 = 6.859, 
Sig. = 0.023). hypertensive parity mean (3.4) was higher than non-hypertensive (2.7). 
Elizabeth et.al (2107) found that mothers with 5 para and more 9 times at higher risk to 
have adverse pregnancy outcomes. On the other hand, Al-Shaikh et al. (2017) found that 
grand multiparous ≥ 5 are at the same risks of complications in comparison with other 
parity categories and the grand multiparous were exposed to the most two pregnancy 
associated complications were spontaneous preterm delivery and gestational diabetes 
(9.1%and12.6%, respectively). The researcher attributed the variety of result to the used 
study design.  
4.3. Newborn outcomes 
To explore differences in maternal and newborn adverse pregnancy outcomes between 
hypertensive and non-hypertensive mothers, the researcher conducted inferential analysis 
in this study as illustrated below. 
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Table 4.13: Comparison between hypertensive and non-hypertensive groups in 
stillbirth, birth weight, preterm birth, neonatal admission and neonatal death. 
 
Variable  
Hypertensive 
Non-
hypertensive 
Total 
χ2 Sig. 
Nu. % Nu. % Nu. % 
Stillbirth 
Yes 213 99.1 215 100.0 428 99.5 
2.009 0.249 No 2 0.9 0 0.0 2 0.5 
Total 215 100.0 215 100.0 430 100.0 
Birth weight (LBW) 
Yes 21 10.0 6 2.9 27 1.6 
3.67 0.055 No 189 90 203 97.1 392 98.4 
Total 210 100.0 209 100 419 100.0 
Preterm birth 
Yes 32 15.4 16 7.6 48 6.4 
11.4 0.003 No 176 84.6 193 92.4 369 93.5 
Total 208 100.0 209 100.0 417 100.0 
Neonatal Admission to Hospital 
Yes 26 12.5 14 6.7 40 11.5 
6.114 0.013 No 182 87.5 195 93.3 377 88.5 
Total  208 100.0 209 100.0 417 100.0 
Neonatal death 
Yes 6 2.8 1 0.5 7 9.6 
4.06 0.044 No 207 97.2 214 99.5 423 90.4 
Total 213 100.0 215 100.0 428 100.0 
 
Table (4.13) shows that there was no statistical difference between the two group (χ2= 
2.009, Sig.= 0.249), also fishers exact test was not significant (P= 0.499 ). The percentage 
of stillbirth among study sample was 0.5%. Worldwide, for every 1000 total births in 2015, 
18.4 babies were stillborn, mostly in low-and middle-income countries (WHO, 2016). Our 
result not consistent with other study as the incidence of stillbirth was 13 in Jordan, 9 in 
Iraq, 8 in Saudi Arabia and 13 per 1000 in Egypt in 2013 (WHO, 2013). The researcher 
attributed the differences to the used sample as our result based on a small and WHO study 
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on population based which give more representativeness. Muti et al. (2015) found that 
women with PIH 4.3 times more likely to have stillbirth (OR 4.34, p = 0.0517) in 
Zimbabwe. While, A cross-sectional study which based on WHO multi-country survey 
shows stillbirth incidence was higher among women with eclampsia (15.3%), women with 
pre-eclampsia (6.4%) (Abalos et al., 2014). On the other hand, according a study 
conducted in the United States showed that the hypertensive disorders responsible for 9.2% 
(95% CI) of all stillbirths (The Stillbirth Collaborative Research Network Writing Group, 
2011). Also this result not consistent with Korde-Nayak Vaishali et al. (2008) who found 
that the stillbirth rate was 35.2/1000. And 58.3% of total stillbirths were antepartum 
stillbirths in India. The researcher thinks in general that the stillbirth is related to HTN in 
pregnancy as adverse outcome, women with preeclampsia/eclampsia, HELLP syndrome, 
placenta previa at higher risk to have stillbirth in addition to other obstetric conditions and 
medical diseases.  
Also stillbirth more frequently occur before delivery and might be preterm or term. In this 
study, findings indicated that our result was vary from others, due to study sample size as 
most of stillbirth relevant studies depend on a large samples (population-based). Moreover, 
the differences exist between countries as United States had own definition for stillbirth 
(after 20 weeks of gestation), while, WHO calculated stillbirths after 28 weeks of gestation 
and other countries after 24 weeks. However, stillbirth considered as a neglected public 
health problem which need more attention and analysis.  
Birth Weight  
Table (4.13) shows that There is a statistical significant differences between the two group 
in birth weight (χ2=11.4, Sig.= 0.003). The differences for hypertensive group As 21 
(10.0%) of hypertensive and 6 (2.9%) of non-hypertensive group had a low birth weight. 
Also the hypertensive birth mean (3041.6)was lower than non-hypertensive (3404.4). this 
result is consistent with different studies as in Jordan, Khader et al. (2017) found that the 
LBW rate among hypertensive mothers with preeclampsia/eclampsia was 32.5% and non-
hypertensive 8.3%, and Muti et al. (2015) found that women with PIH were more likely 
three times to deliver a low birth weight baby (OR 3.0, p = 0.0115). However other studies 
no consistent with our result as Bener et al. (2012) found that the incidence of low birth 
weight (<2500 g) was 6.7% with statistically significant differences in APH (Adj. OR 1.6; 
95% CI 1.1–2.5, p-0.046) and was not significant in HTN in Pregnancy. The researcher 
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attributed the last result to used methodology it was hospital-based prospective and the 
mothers were selected not by the presence of LBW, while this study is comparative with 
equal numbers of hypertensive and non-hypertensive mothers. Moreover, the last study 
was related to HTN in pregnancy as APH mostly associated with HTN in Pregnancy. The 
researcher opinion was that LBW adverse pregnancy outcome is a result of a different and 
interrelated factor and conditions like chronic maternal diseases (HTN, Anemia, etc.), 
parity, gravidity and age, but very important one was HTN in pregnancy as the mother at 
higher risk to have a wide range of complications such as APH, PPH, HELLP syndrome 
and preeclampsia/eclampsia which indicate an immediate medical intervention by 
pregnancy termination either by induction or CS delivery regardless of gestational age in 
order to save the mother or the baby as early as possible, all of which can cause LBW. 
Finally the LBW can increase infant morbidity and mortality.  
Preterm birth 
Table (4.13) shows that a statistical significant difference (χ2 = 6.114, sig.= 0.013) in 
preterm birth for the hypertensive group as 32 (11.5%) of hypertensive and 16 (7.6%) of 
non-hypertensive had preterm birth. It is clearly that the percentage of preterm birth among 
hypertensive mother was higher than non-hypertensive. The study results is congruent with 
Abdelhady & Abdelwahid (2015) study result they found that the preterm births were 
(8.2%) among all deliveries, and the affection with HTN, was higher among preterm labor 
mothers as 43.9% comparing with 18.3% of full-term mothers in Egypt.  
Also the study result was consistent with Dekker et al. (2012) who found that mild HTN 
was a risk factor for preterm birth (OR-9.65, 95%, CI 2.5-37.1), and Kheir et al. (2014) 
who found that the most of the babies with LBW were found in the PIH group, where, 
babies with VLBW were found in the preeclampsia group and there was significant 
correlation between the birth weight and type of hypertensive disorder in pregnancy (P= 
0.01). The researcher attributes this result to the effect of HTN and its management on the 
newborn. Newborns of hypertensive mothers are at higher risk to be delivered before 37 
weeks of gestation due to related hypertensive conditions during pregnancy which required 
pregnancy termination in addition to obstetric conditions. 
  
68 
Neonatal Admission to Hospital 
Table (4.13) shows that neonatal admission is found in 9.6% in study sample, 12.5% of 
hypertensive group and 6.7% in non-hypertensive group. The differences between the 
hypertensive and non-hypertensive groups reach statistically significant level (χ2 = 4.06, P 
= 0.044). All differences were for the hypertensive group. This significant differences were 
consistent with Abalos et al. (2014) who found that the neonatal intensive care unit 
admissions women with eclampsia (32.02%), women with pre-eclampsia (25.84%) and 
women without pre-eclampsia/eclampsia (6.24%). The researcher thinks that it was 
expected that the admission percentage was more among hypertensive mothers as the 
mothers with HTN considered as high risk pregnancy due to presence of the effect of HTN 
on the mother, placenta and fetus, in addition to increased risk of pregnancy termination 
along with used medication which put both the mother and newborns at higher risk to have 
more complications such as prematurity, LBW, respiratory distress syndrome, jaundice, 
stillbirth and other conditions, which increase the infant morbidity and mortality. 
Regardless the study results, it was some limitation as the Apgar score was not calculated 
due to the study design. 
Neonatal Death 
Table (4.13) shows that there was no statistical differences between hypertensive and non-
hypertensive group in neonatal death (χ2 = 3.67, sig.= 0.055). In GG, during 2013 the 
neonatal mortality was 22.4 per 1000 live birth (van den Berg et al., 2015). The study 
result was not consistent with Abalos et al. (2014) who found that the early neonatal death 
among women with eclampsia (8.61%), women with preeclampsia (3.04%) and women 
without pre-eclampsia/eclampsia (0.82%).  
The researcher attributed the differences between the studies to the selected target 
population of studies and also to calculate neonatal mortality rate needs a large sample or 
population based study which not applicable in this study where used comparative design 
to describe neonatal death as adverse newborn outcome among hypertensive mothers. In 
general the researcher thinks that neonatal death to some extent is related to the HTN. the 
mother with a high risk pregnancy may be required termination of pregnancy by induction 
or CS which associated with a range of newborn complication as preterm delivery, 
respiratory distress and jaundice. Moreover, hypertensive mothers also had another risk as 
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they used a some medication such as antihypertensive agents with their side effect on the 
mother and newborn.  
4.4. Maternal outcomes 
Table 4.14: Comparison between study groups by mode of delivery. 
Variable 
Hypertensive 
Non-
hypertensive 
Total 
χ2 Sig. 
No. % No. % No. % 
Mode of delivery 
Spontaneous normal 
vaginal delivery    
(SNVD)  
77 35.9 162 75.3 239 55.6 
67.289 0.001 Cesarean section  
(CS) 
80 37.2 35 16.3 115 26.7 
Induction 58 26.9 18 8.4 76 17.7 
Total 215 100.0 215 100.0 430 100.0 
 
HTN in pregnancy can cause a range of adverse pregnancy outcomes; pregnancy 
termination may prevent and/or minimize the occurrence of such outcomes and save the 
mother and newborn.  
Table (4.14) shows that there was a statistical significant differences between the 
hypertensive and non-hypertensive mothers in mode of delivery (χ2 = 67.289, sig.= 0.001). 
The differences for hypertensive group as CS and assisted delivery were higher 
respectively in hypertensive group (37.2%, 6.9%) compared to non-hypertensive group 
(16.3%, 8.4%). However, UNRWA (2017) reported that the C-Section among reported 
deliveries was 18.9% in GG. The researcher thinks that the study result (26.7%) is 
relatively congruent with the of UNRWA result (around 19%), noting that the UNRWA 
result based on a normal population, but this study 50% of sample belonged to a high risk 
pregnancy with HTN which gives about 37% -CS deliveries.  
On the other hand, this study not congruent with other study, Muti et al. (2015) found that 
12.46 % of mothers delivered by caesarean section and 1.04 % had an assisted delivery 
among hypertensive women. This differences may be attributed to the sample small size 
(n=289) with around 19% with only mild PIH among hospitalized women. Senkoro et al. 
(2017) found that 73.3% of a women with placenta previa had a delivery by CS (OR 9.68; 
95% CI: 6.66–14.1). Moreover, Kheir et al. (2014) found that about 58% of the 
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hypertensive women were multiparous, 98.5 % of them were delivered by caesarean 
section and 43% of them were carried out as an emergency procedure. The last study was 
conducted among in the neonatal intensive care unit for a hypertensive mothers, so that’s 
explain higher number of CS as among very risky group. Also, Hassan (2013) found that 
17.8% of hypertensive mothers had normal vaginal delivery, while 82.19% had cesarean 
section, this result regarding CS was higher than this study, this variations explained by the 
used design it was prospective hospital based among mothers with HTN. In addition to the 
previous studies, this study is consistent with Bouzari et al. (2013) study which resulted 
that the induction of labor was more prevalent among HELLP (64.5%), Partial HELLP 
Syndrome (43.3%) and preeclampsia (40.4%) and Cesarean section: HELLP (23.5%, 
P<0.001), preeclampsia(3.4%) and PHS(3%).  
The researcher thinks that all of the above conditions are considered as adverse maternal 
outcome and may related directly or indirectly to HTN in pregnancy as in preeclampsia 
40%-Induction (assisted delivery) and 3.4%-CS.  
Table 4.15: Preeclampsia/eclampsia among hypertensive group. 
 
Preeclampsia 
Hypertensive 
No. % 
No 152 70.7 
Yes 63 29.3 
Total 215 100.0 
 
Table (4.15) shows that 14.7% of all mothers, 29.3% of mothers with HTN had 
preeclampsia/eclampsia, where is no cases of preeclampsia/eclampsia among non-
hypertensive mothers. the differences were for hypertensive group. The findings indicated 
the possible impact of HTN in occurrence of such outcome. 
Preeclampsia/eclampsia is one of the most serious complication among pregnant which 
associated directly and strongly to the HTN. In this line, findings of the table (4.15) shows 
that only hypertensive mothers had preeclampsia/eclampsia 14.7% of all mothers (29.3% 
of hypertensive), as every woman with preeclampsia/eclampsia must had increased blood 
pressure in addition to other symptoms. Pregnant women with preeclampsia/eclampsia 
may have uncontrollable severe hypertension, pulmonary edema, disseminated 
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intravascular coagulation, abruption placenta in addition to other complications (ACOG, 
2013).  
The study result is relatively consistent with other study, Kheir et al. (2014) found that 
among 3168 deliveries gives a prevalence of 2.17% HTN during prgnancy. Of these, 
(42%) were pregnancy induced hypertension while (21.7%) and (4.3%) had preeclampsia 
and eclampsia respectively. Also congruent with Hassan, (2013) study with findings 
indicates that 60% of mothers had gestational hypertension, 28.6% pre-eclamtic toxemia 
and 4.1% eclampsia.  
This result attributed to the matching to our study as both conducted among hypertensive 
women. On the other hand this result not congruent with Khader et al., (2017) study where 
found that the incidence rate of preeclampsia was 1.3% among women in Jordan. The 
researcher attributes the differences to the type of Khader et al. study which was a 
comprehensive national study and all the data was obtained from specific hospitals in 
Jordan.  
However, Manjusha et al. (2014) found that prevalence of hypertensive disorders of 
pregnancy was 7.8%, of them 71.2% with preeclampsia. The previous result (71.2%) was 
higher than this study result (14.7%) and the researcher attributed it to a used study sample 
and methodology, this study was comparative while the other was hospital based which 
contained very risky hypertensive women who were admitted to hospital, in addition, the 
researcher cannot calculate the prevalence of preeclampsia/eclampsia. On the other hand, 
this study not consistent with Muti et al. (2015) study which indicated that the prevalence 
of PIH, preeclampsia and eclampsia were 19.4 %, 1.7 % and 0.3 % respectively. The 
researcher attributed this differences to sample size, it was smaller than this study only 289 
participants, the study was conducted at hospital and the prevalence of eclampsia and 
preeclampsia were 10.4% and 2.1% among (19.4%) but this study comparative and the 
hypertensive group consisted of PIH in addition to chronic HTN.  
While, a study conducted by WHO showed that the incidence of hypertensive disorders of 
pregnancy was 2,7% (8542 from a total 313030 women in database), the total figures for 
chronic hypertension, pre-eclampsia and eclampsia are 0.29%, 2.16% and 0.28% of all 
deliveries respectively (Abalos et al., 2014). The WHO result is lower than the findings of 
this study (29.3%), as WHO study more representative as it a cross-sectional multicountry 
survey and conducted at secondary and tertiary health level in addition to the very large 
sample. While, this study is comparative on the level of primary health care with limited 
sample size.  
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Also, Gongora & Wenger (2015) found that Preeclampsia/eclampsia was occurred in 3% 
to 5% of all pregnancies, this result was lower as it a review study. Also, Prude et al. found 
that the preeclampsia incidence of 2.31% and About 10% of all observed cases progressed 
to eclampsia. The percentage of women with preeclampsia/eclampsia is 14.7% among all 
mothers, this result is higher than the above mentioned results, the researcher thinks its 
related to, in some studies the preeclampsia/eclampsia incidence or prevalence calculated 
among all mothers (hypertensive and non-hypertensive) but in this study the researcher 
cannot do so, differences in sample size and type of studies as some of them were a 
hospital based or multicountry surveys, in this study under preeclampsia/eclampsia 
considered a wide scope of cases such as preeclampsia, eclampsia and chronic HTN with 
superimposed preeclampsia/eclampsia and some hospital doctors may over diagnose this 
condition without proper documentation, and may treat some cases with PIH as having 
preeclampsia/eclampsia to prevent the expected serious fetomaternal adverse outcomes. In 
addition, some studies either higher or lower in the results compared with study, that’s 
depends how we looking and understand the numbers, if it among high risk pregnancy as 
having HTN or among all mothers.  
 
Table 4.16: Comparison between hypertensive and non-hypertensive groups in 
occurrence of antepartum and postpartum Hemorrhage. 
 
Variable 
Hypertensive 
Non-
hypertensive 
Total 
χ2 Sig. 
No. % No. % No. % 
Antepartum Hemorrhage (APH) 
No 185 86.0 209 97.2 394 91.6 
17.462 0.001 Yes 30 14.0 6 2.8 36 8.4 
Total 215 100.0 215 100.0 430 100.0 
Postpartum Hemorrhage (PPH) 
No 200 93.0 212 98.6 412 95.8 
8.350 0.003 Yes 15 7.0 3 1.4 18 4.2 
Total  215 100.0 215 100 430 100.0 
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Antepartum and Postpartum hemorrhage (APH, PPH) were a common and serious 
bleeding complications during pregnancy and delivery which considered as common 
complications among adverse maternal outcomes.  
Table (4.16) shows that the occurrence of APH 8.4% of all mothers and among 
hypertensive (14%) was higher compared to non-hypertensive (2.8%). This result 
regarding APH is relatively consistent with Bener et al. (2012) study with prevalence of 
APH 15.3% and family history of hypertension (OR 1.78; 95%CI 1.30-2.44; P<0.001) was 
significant. Bener et al. (2013) also conducted other study and found that women aged 35 
years or older had a significantly higher risk of APH (17.9% vs. 13.7%; P = 0.042) than 
younger women. while, the study result not congruent with Takai et al. (2017) study, where 
the prevalence of APH 1.2%, the common causes were abruptio placenta (68.3%) and 
placenta previa (30.0%). Also, women with placenta previa had increased odds of APH 
(OR 9.21; 95% CI: 5.3–16.0). The researcher thinks that APH in this study is higher than 
other, as APH may include all the bleeding conditions resulted from placenta previa, 
abruption placenta and any vaginal bleeding during the pregnancy, which may occur in 
second and third trimester. Also, sometimes the diagnosis of APH did not based on specific 
bleeding causes. In general, APH might be more related to placental related conditions 
rather than to HTN.  
Findings of Table (4.16) shows that the percentage of PPH occurrence was higher among 
hypertensive (7%) compared to non-hypertensive mothers (1.4%) and 4.2% of all mothers 
(p=0.001).This result is higher than study conducted by Michael et al. (2013) which 
resulted that among 8,571,209 deliveries, 25,906 (3.0 per 1000) were complicated by 
severe PPH (P for yearly trend <.0001), Significant risk factors were maternal age ≥35 
years ( aOR, 1.5; 95% CI, 1.5–1.6), multiple pregnancy (aOR, 2.8; 95% CI, 2.6–3.0), 
fibroids (aOR, 2.0; 95% CI, 1.8–2.2), preeclampsia (aOR, 3.1; 95% CI, 2.9–3.3), 
amnionitis (aOR, 2.9; 95% CI, 2.5–3.4), placenta previa or abruption (aOR, 7.0; 95% CI, 
6.6–7.3).  
On the other hand, Al-Kadri et al. (2009) found that preeclampsia and history of APP by 
>6 and >8-fold increased the risk for PPH respectively. Moreover, Senkoro et al. (2017) 
found that women with placenta previa had increased odds of PPH (OR 17.6; 95% CI: 8.6–
36.2).The researcher attributed this differences to used methodology and sample size. In 
addition to the PPH is related more to, preeclampsia/eclampsia which considered as severe 
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complication of HTN in pregnancy, frequently associated with placental conditions and 
may be increased due to over diagnosis as clinical diagnosis in hospitals.  
 
Table 4.17: Comparison between hypertensive and non-hypertensive groups in 
occurrence of abruptio placenta, placenta previa and HELLP Syndrome 
Variable 
Hypertensive Non-hypertensive Total 
χ2 Sig. 
No. % No. % No. % 
Abruptio placenta 
No 210 97.7 213 99.1 423 98.4 
1.307 0.225 Yes 5 2.3 2 0.9 7 1.6 
Total 215 100.0 215 100.0 430 100.0 
Placenta previa 
No 214 99.5 214 99.5 428 99.5 
0.000 0.751 Yes 1 0.5 1 0.5 2 0.5 
Total 215 100.0 215 100.0 430 100.0 
HELLP Syndrome  
No 213 99.1 215 100.0 428 99.5 
2.009 0.249 Yes 2 0.9 0 0.0 2 0.5 
Total   215 100.0 215 100.0 430 100.0 
 
Table (4.17) shows that only 1.6% of all mothers, 2.3% of hypertensive and 0.9% of non-
hypertensive had abrupio placenta (χ2 =1.307, sig.=0.255). While, 0.5% of mothers, 0.5% 
of hypertensive and 0.5% of non-hypertensive had placenta previa (sig.=0.751). However, 
only 2 (0.9%) of hypertensive mothers which account 0.5% of all mothers had HELLP 
syndrome (χ2 = 2.009, sig.=0.249). There are no statistical differences between the 
hypertensive and non-hypertensive mothers in variables of placental abruption, placenta 
previa and HELLP syndrome.  
Abruptio placenta, placenta previa and HELLP syndrome are considered as a severe 
conditions which may lead to severe bleeding and adverse fetomaternal outcomes.  
Placental abruption is most likely occur among smokers, in hypertensive pregnancies, and 
in addition to other conditions (Oyelese & Ananth, 2006).  
The study result as 2.3% of hypertensive group had abruption placenta not congruent with 
other studies as Tikkanen (2010) found that the prevalence of placental abruption is lower 
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in the Nordic countries (0.38–0.51%) compared with the USA (0.6–1.0%) and around 0.4–
1% of pregnancies are complicated by placental abruption. While, Bako et al. (2008) found 
that was statistically significant occurrence of placental abruption among hypertensive 
women (p=0.00, RR=2.60 and OR=14.07) compared with placanta previa. In this study 
were only 2 cases (0.9%) had HELLP syndrome among hypertensive mothers (p=0.249), 
this result is vary from other studies as Mihu et al. (2007) found that the HELLP syndrome 
incidence was 0.17-0.85% of all pregnancies.  
While, Bouzari et al. (2013) found the gestational age (35.72±3.15 WK) at delivery 
(P<0.031) and birth weight (P<0.00) were lower significantly in the women of HELLP 
syndrome, the Induction of labor was more prevalent among HELLP (64.5%), Need to 
ICU was higher in women with HELLP (11.8%, P<0.001), Cesarean section: 
HELLP(23.5%, P<0.001), Abruption placenta: HELLP (17.6%) and Eclampcia: HELLP 
(5.9%) and preeclampsia(2.2%). 
The researcher attributed this differences between this study and other studies regarding 
the occurrence of placenta previa, abrubtio placenta and HELLP syndrome to the under 
diagnosis and poor documentation of such cases at the level of secondary health care, poor 
tertiary level. In addition to the study design and sample. Also the researcher thinks that 
placenta previa might be not related to HTN in pregnancy as its etiology is still unknown. 
4.5 Quality of life 
Table 4.18: Comparison between hypertensive and non-hypertensive by quality of 
life. 
  No. Mean Std T Sig. 
Physical Activity 
Hypertensive 215 66.6 17.4 
-4.936 0.001 
Non-Hypertensive 215 74.4 15.1 
Psychological  
Hypertensive 215 64.3 12.6 
-6.509 0.001 
Non-Hypertensive 215 73.9 17.5 
Social Relationship 
Hypertensive 212 70.5 12.9 
-4.886 0.001 
Non-Hypertensive 213 76.7 12.9 
Environment  
Hypertensive 215 55.1 11.6 
-4.371 0.001 
Non-Hypertensive 215 60.1 12.2 
Overall Satisfaction 
Hypertensive 212 64.2 10.3 
-6.924 0.001 
Non-Hypertensive 213 71.3 10.8 
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Table (4.18) shows that there are statistical significant differences of mean overall 
satisfaction (p=0.001) among hypertensive mothers (64.2) in comparison with non-
hypertensive mean(71.3). It is clear that the mothers with HTN which associated with 
adverse pregnancy outcomes had lower quality of life in comparison to mothers without 
HTN during the last pregnancy.  
The differences were for hypertensive group as overall satisfaction mean foe hypertensive 
group (64.2) lower than non-hypertensive (71.3). The quality of life among hypertensive 
mothers was found lower in all domains. This result means that the mother with HTN are 
exposed not only to the burden of HTN during pregnancy, but also to the related 
conditions, which affect their different perceptions regarding the quality of life domains. A 
similar result was also found in another study conducted among hypertensive patients in 
Poland showed that comorbidities and the number of medications are the primary factors 
associated with lower health-related quality of life in hypertensive patients and women 
reported lower health-related quality all in dimensions (Zygmuntowicz et al., 2012). 
However, to some extent this result is partially consistent with other result, as Ha et al. 
(2014) conducted a study with findings that the people with HTN has moderate quality of 
life except psychological health was relatively low ( mean=49.4 ±12.7).  
The researcher attributed this differences to study population as in our study was mothers 
with or without HTN in last pregnancy, while the other study was among people with HTN 
(males and females) in the rural area. Melchiors et al., (2010) found that the highest mean 
satisfaction for social relationship among hypertensive people in Brazil. However, the 
researcher thinks the differences in results between different study related the sample size 
and the used instrument, in our study WHOQOL-BREF while, other used WHOQOL-100 
or SF-36.  
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Chapter 5: Conclusion and Recommendation 
 
5.1. Conclusion  
Hypertension in pregnancy is an important and challenging public health problem in 
developing and developed countries. Hypertension could be interfered with Pregnancy and 
may cause different pregnancy outcomes with unexpected adverse events. In this line, this 
study aimed to identify the possible effect of pregnancy hypertension on pregnancy 
outcomes and maternal adverse events among women attended UNRWA's  health care 
services in Gaza governorates, in order to reduce the incidence of adverse pregnancy 
outcomes and improve maternal and child health care. An analytical comparative study 
was carried out among mothers who had hypertension and mothers who had not 
hypertension in last pregnancy. The sampling was stratified proportional applied for 
UNRWA health centers in Gaza governorates with sample size of 430 respondents, 215 
mothers in hypertensive group and 215 mothers in non-hypertensive group.  A validated 
constructed questionnaire with face to face interview, in addition to used WHOQOL-BREF 
for Quality of life assessment were carried to all respondents along with medical records 
review in form of abstraction sheet. P values less than 0.05 is considered statistically 
significant, Chi square and t-test were used.  
Mothers with hypertension in pregnancy still at increased risk for developing of adverse 
pregnancy outcomes regarding to maternal and newborn complication in comparison to 
mothers without hypertension. Among socio-demographic characteristics, the significant 
differences in pregnancy outcomes were observed in maternal age at last delivery  and 
residency area. Regarding the obstetric profile, the gravity, parity, BMI, routine antenatal 
care visits, systolic and diastolic blood pressure and postnatal care were had significant 
differences (p ≤ 0.05) between hypertensive and non-hypertensive mothers. In the context 
of maternal outcomes, the researcher found that the mothers with hypertension in last 
pregnancy had statistically significant differences (p ≤ 0.05) in pregnancy termination, 
pre/eclampsia, antepartum and postpartum hemorrhage, while no significant differences (p 
>0.05) in placental abruption, placenta previa and HELLP syndrome compared to non-
hypertensive mothers. 
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Newborn outcomes also affected, the statistical significant differences were observed 
between the two groups in preterm birth (χ2 =6.114, p=0.13)., low birth (χ2 =11.4, 
p=0.003) weight and neonatal admissions (χ2 =4.06, p=0.044).  
Regarding the quality of life, the overall satisfaction was lower among mothers with 
hypertension with moderate quality of life and these differences were statistically different, 
in addition to 79.1% of mothers with pregnancy-induced-hypertension (PIH) were 
recovered. 
5.2. Recommendations  
1. Expansion of preconception care coverage in order to prepare women to enter 
pregnancy in optimal health and controlled blood pressure before pregnancy.  
2. Enhancing early ANC registration in order to timely detection and correction of any 
deviation from normal pregnancy pattern and enhancing close follow up for the 
women with HTN and high risk pregnancy. 
3. Improve the referral system and feedback mechanism between primary and 
secondary health care.  
4. Ensuring effective and timely postnatal care and family planning. 
5. Improving health education program especially among females at teen ages through 
effective school heath program and effective counseling among healthcare 
providers regarding HTN and adverse pregnancy outcomes. 
6. Enhancing community participation and mobilization, the community should be 
educated about pregnancy and delivery preparedness and the importance of having 
a birth plan and how can HTN affect pregnancy and vice versa. 
7. Psychosocial support should be provided to mothers with hypertension and adverse 
pregnancy outcome as early as possible. 
8. Conducting more researches in different aspects of pregnancy associated with HTN 
or other chronic conditions. Case control studies to determine risk factors for each 
adverse pregnancy outcome in addition to hospital based studies.  
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Annex (1): Palestine map 
 
Source:(PCBS, 2016)  
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Annex (2) Sample size calculation 
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Annex (3) Proposed No. participants.   
Health 
Center 
No. Women 
With HTN-
2015 
Proportionate 
percentage 
No. 
proposed 
Hypertensive 
group 
No. proposed 
Non-
Hypertensive 
group 
Total 
Sabra 144 10.6 23 23 46 
Rimal 213 15.6 34 34 68 
Nuesirat 246 18 38 38 76 
D Balah 153 11.2 25 25 50 
Maan 267 19.6 42 42 84 
Khan-
Younis 
339 25 53 53 106 
Total 1362 100% 215 215 430 
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Annex (4): Committee panel control  
 
No. Name Position 
1. Dr. Bassam Abu-Hamad Al-Quds University 
2. Dr. Yahia Abed Al-Quds University 
3. Dr. Yousef AlJeesh Islamic University 
4. Dr. Khitam Abu-Hamad Al-Quds University 
5. Dr. Saleh Isa Field Disease Control Officer-UNRWA 
6. Dr. Mariam A/Qader Field Family Heath Officer-UNRWA 
7. Dr. Taysie El-Ammasi Senior Medical Officer-UNRWA 
8. Dr. Zohier El-Khatib Field Family Heath Officer –UNRWA 
9. Dr. Imad El-Aour Area Health Officer-UNRWA 
10. Dr. A/Qader Al-Habil Senior Medical Control Officer-UNRWA 
11. Dr. Kefah Al-Najjar Senior Medical Officer-UNRWA 
12. Dr. Ahmad Al-Shaer Islamic University 
13. Huda Samour Senior Staff Nurse-UNRWA 
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  المحترم              ........................................................ السيد /
 
  :بعدتحية طيبة و
  ستبانةتحكيم إ
 
علم الأوبئة بجامعة القدس  –, ملتحق ببرنامج ماجستير صحة عامة الطالب خليل جميل القطراوى أنا 
 أبو ديس وأقوم بإعداد رسالة الماجستير كمتطلب تكميلي لنيل الدرجة والتي هي بعنوان :
 
 ta semoctuO ycnangerP no noisnetrepyH fo tceffE
 yduts evitarapmoc :setaronrevoG azaG ni sretneC htlaeH AWRNU
بداء الملاحظات ة وإفادتنا برأيكم وإقتراحاتكم وإأرجو من سيادتكم التكرم والإطلاع على الإستبان
 الهادفة للتعديل.
 
 مع خالص الشكر والتقدير
 
 
  خليل جميل القطراوى الباحث:
  
 19
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 استبانة المقابلة
 فلسطين  –جامعة القدس 
 ا ـكليــة الدراســات العليــ
 ة ـكليــة الصحــة العامـــ
 
 الأخت الفاضلة: 
 تحية تقدير واحترام وبعد،،، 
برنامج الصحة  -خليل جميل القطراوي طالب ماجستير بجامعة القدس كلية الدراسات العليا أنا الطالب
كمتطلب رئيسي من متطلبات الحصول على شهادة العامة تخصص وبائيات أقوم بإجراء هذا البحث 
التعرف على تأثير ارتفاع ضغط الدم على نتائج الحمل لدى الماجستير، حيث أن الدراسة تهدف إلى 
  السيدات اللواتي يتابعن في عيادات وكالة الغوث في محافظات قطاع غزة.
يرجى التكرم بالإجابة على جميع أسئلة الاستبانة بكل أمانة وصدق، مع العلم أن مشاركتك في هذه 
 الدراسة طوعية، كما أن البيانات التي سيتم جمعها سيتم استخدامها للبحث العلمي فقط. 
دقيقة لاستكمالها مهما تكن المعلومات التي تعطيها سوف  02هذه الاستبانة سوف تستغرق حوالي 
 تبقى سرية وطي الكتمان. 
 
 كل الشكر والتقدير لكم
 الطالب
 خليل جميل القطراوي
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Annex (7): Questionnaire  
 
Effect of Hypertension on Pregnancy Outcomes at UNRWA Health Centers in Gaza 
Governorates – Questionnaire  
 
 
Serial No:  ����  
Date of interview : ……/……/……      
RCN……………………………….               
Research category:  
    1. Hypertensive           2. �Non-hypertensive  
No. of maternal health record…………………………………………….. 
No. of child health record………………………………………………….. 
Governorate:  
  1. �North          2. �Middle        3. �South          
Name of Primary Health care center: ……………………………………….          
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1.Demographic Profile 
1.1. Mother’s age at last delivery: …………. 
1.2. Marital age: …………… 
1.3. Place of residency: 
     1- � City   2- � Village   3- � Camp  
1.4. Education of the mother :       
    1. � Illiterate   2. �Can read and write     3. � Elementary  
    4. � Preparatory    5. � Secondary   6. � Associate diploma  
    7. � Bachelor and above 
1.5. Education of the husband :      
    1. � Illiterate   2. � Can read and write     3. � Elementary  
    4. � Preparatory    5. � Secondary   6. � Associate diploma  
    7. � Bachelor and above 
1.6 Current working status: 
     1. � Working  2. � Nonworking.       If nonworking skip to Q1.7 
1.7. Current working status for husband :  
      1. � Working  2. � Nonworking  
1.8.1. How much in your family income (NIS) ?  
      1. � Less than 1000 NIS             2. � 1000-2000             3. � 2000-3000 
      4. � More than 3000                   5. � Don't know            6. � Refuse to answer              
1.8.2. Does the current income meet expenses? 
      1- � Yes & Save              2- � Yes  
      3- � Sometimes              4- � No 
1.9. The number of family members (size)  ………………………. 
1.10.1. Type of the family:  
    1- � Nuclear family   2- � Extended family 
1.10.2. Please, specify the total number of persons……….. 
1.11. House ownership: 
    1- � Completely owned                   2- � Family owned               3- � Rented          
    4- � Destroyed during war               5- � Other, specify………..     
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                    2.Obstetric profile  
2.1.1 Number of Pregnancies:……… 
2.1.2.Deliveries:……..  
2.1.3.Abortions………… 
2.2. Interval (by Months) between the last delivery and the previous one?..................... 
2.3. Did you receive preconception care service?  
        1- � Yes                          2- � No    
2.4. Did you have a family history of the following conditions? 1- � Yes      2- � No        
        1- � HTN            2- � DM                  3- � Cardiac conditions           
2.5. Did you have a past history of the following conditions?     1- � Yes      2- � No 
         1- �Chronic HTN           2- �PIH                          3- � Pre/eclampsia  
         4- �Cardiac conditions       5- �Renal conditions        6- �GDM  
         7- �DM                    8- �Hypothyroidism    9- �BA          
        10- �Thalassemia            11- � Others(specify)…….. 
2.6. Did you suffer from hypertensive conditions during the last pregnancy?  
         1- � Yes      2- � No      If No, skip to Q 2.11 
2.7. If yes, which type of the following : 
         1- � Chronic HTN           2- � Pregnancy-induced-HTN   
2.8. If chronic HTN, when was it firstly diagnosed? Specify (year)…………………. 
2.9. If PIH was diagnosed during pregnancy, did you take treatment on time in the last 
pregnancy? 
         1. � Yes    2. � No 
2.10. During the puerperium period (42 Days), did you take treatment on time in the last 
pregnancy?  
          1. � Yes    2. � No 
2.11. When did you receive PNC service after delivery? Specify in days………… 
2.12. If you suffered from PIH, did you receive the final PNC assessment visit  (40-42 days 
after delivery)?                                            
      1- � Yes, by MW  2- �Yes by Dr only  3- �Yes by both  4- �No 
2.13. If yes, did you recover from the PIH?       
        1- � Yes    2- � No 
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The following questions are about the previous pregnancies (excluding the last 
pregnancy) 
2.14. Regarding the newborn outcome, did you experienced any of the following: 
 
Outcome Yes No Numbers 
a- Stillbirth    
b- Neonatal death , if yes, specify the age by days…..          
c- Low Birth Weight (˂ 2500 gm.) baby    
d- Prematurity (< 37 weeks)      
 
 
2.15.1. Did you experience any newborn complications related to the previous pregnancies?            
       1- � Yes                                 2- � No  if no skip to Q2.25 
2.15.2 If  Yes, specify…….                                    
2.16.1. Did you suffer any maternal complications related to the HTN during previous 
pregnancies?            
       1- � Yes                                  2- � No 
2.16.2 If Yes, specify…….. 
  
96 
 
                    3.Maternal outme  
3.1.Have you suffered from any complications in last pregnancy or in the peurperium? 
 
 Complications Yes No 
a- Bleeding in early pregnancy (up to 28 weeks)    
b- Bleeding in late pregnancy (28 to expulsion of fetus)            
c- Bleeding after delivery, specify the day (if yes)………………….                                                            
d- Abruptio placenta   
e- Placenta previa           
f- Pre/eclampsia   
g- HELLP syndrome   
h- Disseminated intra vascular coagulopathy   
i- Others, (specify) ……………………    
 
3.2.Did you hospitalized during the last pregnancy? 
      1- � Yes  2- � NO          
3.3.1.Was blood transfusion required?   
       1- � Yes                            2- � No 
3.3.2.What was the indication:   
       1- � APH                          2- � PPH                            3- � Pre/Eclampsia  
       4- � APH + Preeclampsia           5- � PPH + Preeclampsia 6- � Others………                       
 
Delivery/ Termination of Pregnancy: 
3.4.1. Mode of delivery       
       1- � SNVD               2- � CS.          3- � induction 
 
3.4.2.What was the CS indication:   
       1- � Previous CS        2- � P.R.O.M          3- � pelvis Abnormalities 
       4- � Others……….    5- � Hemorrhage 
3.5.1. Place of delivery        
       1- � Hospital.               2- � Private clinic   3- � Home 
 
3.5.2. If hospital, select:      
       1- � Governmental hospital  2- � Private hospital 
3.6. Pregnancy outcomes :     
       1- � Singleton       2- � Multiple   
3.7. Pregnancy termination,       
       if No. skip to Q 4.1      
       1- � Yes    2- � No  
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3.8. Type of termination:  
       1- � In term pregnancy   2- � Before term pregnancy 
3.9. Method of termination 
       1- � CS    2- � induction 
3.10. What was the indication for termination?      
Indications Yes No 
1. Antepartum hemorrhage   
2. Pre/eclampsia   
3. Augmentation   
4. Deterioration of fetal status   
5. Failure of induction (for CS.)   
6. Oligohydramins    
7. Previous scars   
8. P.R.O.M   
9. Other (specify)________________________   
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4.Newborn outcome 
4.1. Neonatal death    
        1- � Yes, specify the age by days…….  2- � No 
4.2. Delivery room resuscitation  
        1- � Yes      2- � No 
4.3.1 Did the new born suffer from any medical condition?      
        1- � Yes      2- � No 
4.3.2.If  Yes, specify………………  
4.4.1. Did the new born suffer from any congenital condition?      
        1- � Yes      2- � No 
4.4.2.If Yes, specify …………. 
4.5.1. Neonatal admission  to intensive care unit:              
        1- � Yes                          2- � No 
4.5.2. If Yes, what was the cause:      
         1- � Prematurity                       2- � RD                   
         3- � Jaundice       4- � Others……….                                                         
4.5.3.If Yes, specify how long.……., 
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Abstraction sheet 
 
Obstetric profile 
1. Gestational age at last delivery ……….. week  
2. Number of pregnancies:………… 
3.Deliveries:…….. 
4.Abortions…………. 
5. Number of PCC visits …………… 
6. Gestational age at registration for ANC in last pregnancy……..  
7. Number of routine ANC checkups................... 
8. Number of non-routine ANC checkups........... 
9. Risk scoring of last pregnancy at first ANC  visit:   
          1- � Normal         2- � Alert     3- � High 
10. Risk scoring of last pregnancy at last ANC  visit:   
          1- � Normal   2- � Alert     3- � High 
11. BMI at registration………………… 
12. Mean Hb …………………… 
HB. 
NO 1 2 3 4 5 6 
RESULT       
 
 
13. BP measurement: 
BP. 
 REG 24 LAST PN1 PN2 1 2 MEAN 
SYS        Q.14….. 
DIA        Q.15….. 
 
14. Gestation at which BP. Increased......................... 
15. Gestation at which  PIH was diagnosed………. 
16. Gestation at which  chronic HTN was diagnosed………. 
17. Final PNC assessment (40-42 days after delivery) for the case of PIH:  
 1- � Yes   2- � No 
18. Recovered from PIH:        
 1- � Yes   2- � No 
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Maternal outcome 
19.Old NCD file                      
 1- � Yes   2- � No 
20.NEW chronic HTN referred to NCDs    
 1- � Yes   2- � No 
21.PIH referred to NCDs                              
 1- � Yes               2- � No 
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Newborn outcome 
22- Live     1- � Yes   2- � No 
23- Still birth                          1- � Yes   2- � No  
24- Sex                                    1- � Male   2- � Female 
25- Weight of baby at birth in grams…………  
26- Head circumference ………………. 
27- Prematurity (< 37 weeks)      1- � Yes    2- � No 
 
IF TWINS 
22.2. Live     1- � Yes   2- � No 
23.2. Still birth                          1- � Yes   2- � No  
24.2. Sex                                   1- � Male   2- � Female 
25.2. Weight of baby at birth in grams…………  
26.2. Head circumference ………………. 
27.2. Prematurity (< 37 weeks)      1- � Yes    2- � No 
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Annex (8): WHOQOL – BREF in English language   
 
 
The following questions ask how you feel about your quality of life, health, or other 
areas of your life. I will read out each question to you, along with the response 
options. Please choose the answer that appears most appropriate. If you are unsure 
about which response to give to a question, the first response you think of is often the 
best one. 
 
Please keep in mind your standards, hopes, pleasures and concerns. We ask that 
you think about your life in the last four weeks. 
 
   
Very poor 
 
Poor 
Neither poor 
nor good 
 
Good 
 
Very good 
1. How would you rate your 
quality of life? 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
 
   
Very 
dissatisfied 
 
Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
 
Satisfied 
 
Very 
satisfied 
2. How satisfied are you with your 
health? 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
The following questions ask about how much you have experienced certain things in 
the last four weeks. 
 
   
Not at all 
 
A little 
A moderate 
amount 
 
Very much 
An extreme 
amount 
3. To what extent do you feel that 
physical pain prevents you 
from 
doing what you need to do? 
1 2 3 4 5 
4. How much do you need any 
medical treatment to function 
in your daily life? 
1 2 3 4 5 
5. How much do you enjoy life? 1 2 3 4 5 
6. To what extent do you feel your 
life to be meaningful? 
 
1 
 
2 
 
3 
 
4 
 
5 
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Not at all 
 
A little 
A moderate 
amount 
 
Very much 
 
Extremely 
7. How well are you able to 
concentrate? 
 
1 
 
2 
 
3 
 
4 
 
5 
8. How safe do you feel in your 
daily life? 
 
1 
 
2 
 
3 
 
4 
 
5 
9. How healthy is your physical 
environment? 
 
1 
 
2 
 
3 
 
4 
 
5 
The following questions ask about how completely you experience or were able to do 
certain things in the last four weeks. 
 
   
Not at all 
 
A little 
 
Moderately 
 
Mostly 
 
Completely 
10. Do you have enough energy for 
everyday life? 
 
1 
 
2 
 
3 
 
4 
 
5 
11. Are you able to accept your 
bodily appearance? 
 
1 
 
2 
 
3 
 
4 
 
5 
12. Have you enough money to 
meet your needs? 
 
1 
 
2 
 
3 
 
4 
 
5 
13. How available to you is the 
information that you need in 
your day-to-day life? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
14. To what extent do you have the 
opportunity for leisure 
activities? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
   
Very poor 
 
Poor 
Neither poor 
nor good 
 
Good 
 
Very good 
15. How well are you able to get 
around? 
 
1 
 
2 
 
3 
 
4 
 
5 
 
   
Very 
dissatisfied 
 
Dissatisfied 
Neither 
satisfied nor 
dissatisfied 
 
Satisfied 
 
Very 
satisfied 
16. How satisfied are you with your 
sleep? 
 
1 
 
2 
 
3 
 
4 
 
5 
17. How satisfied are you with 
your ability to perform your 
daily living activities? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
18. How satisfied are you with 
your capacity for work? 
 
1 
 
2 
 
3 
 
4 
 
5 
19. How satisfied are you with 
yourself? 
 
1 
 
2 
 
3 
 
4 
 
5 
20. How satisfied are you with your 
personal relationships? 
 
1 
 
2 
 
3 
 
4 
 
5 
21. How satisfied are you with 
your sex life? 
 
1 
 
2 
 
3 
 
4 
 
5 
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22. How satisfied are you with the 
support you get from your 
friends? 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
23. How satisfied are you with the 
conditions of your living place? 
 
1 
 
2 
 
3 
 
4 
 
5 
24. How satisfied are you with your 
access to health services? 
 
1 
 
2 
 
3 
 
4 
 
5 
25. How satisfied are you with 
your transport? 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
The following question refers to how often you have felt or experienced certain 
things in the last four weeks. 
 
   
Never 
 
Seldom 
 
Quite often 
 
Very often 
 
Always 
26. How often do you have 
negative feelings such as blue 
mood, despair, anxiety, 
depression? 
1 2 3 4 5 
 
 
Do you have any comments about the assessment? 
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   egaugnal cibarA ni FERB – LOQOHW :)9( xennA
 التعليمات
يستفسر عما تشعر به فيما يتعلق بنوعية حياتك و صحتك و نواحي أخرى من حياتك, هذا الإستبيان 
عين , نرجو اختيار نرجو الإجابة على جميع الأسئلة. إذا لم تكن متأكد من الإجابة على سؤال م
قيمك و و هذا قد يكون ردك الأول في أحيان كثيرة . نرجو أن تضع في اعتبارك  .الجواب الأنسب
. قد يكون الماضيين مثلا ين. نطلب أن تفكر في نمط حياتك خلال الشهر يمنعك و يشغلك آمالك و ما
 :السؤال
 
 دائما كثيرا نوعا ما قليلا لا يوجد 
 5 4 3 2 1 هل تحصل على أي دعم أو مساعدة من الأخرين ؟
 
 ينالشهرالرقم الذي يصف مقدار الدعم أو المساعدة من الآخرين خلال عليك وضع دائرة حول 
) إذا كنت قد حصلت على دعم كبير من الآخرين 4قم (هكذا فإنك ستضع الدائرة حول الرالماضيين. و
 كالآتي 
 
 دائما كثيرا نوعا ما قليلا لا يوجد 
 3 2 1 هل تحصل على أي دعم أو مساعدة من الأخرين ؟
 
 5
 
 تتمناها من الآخرين خلال) إذا لم تحصل على أي دعم أو مساعدة 1قد تضع الدائرة حول الرقم (
 . ين الماضيينالشهر
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يرجى قراءة كل سؤال و تقيم مشاعرك ووضع الدائرة حول الرقم الذي يعطي أفضل إجابة * 
 بالنسبة لك.
 
 جيدة جدا   جيدة لا بأس سيئة سيئة للغاية كيف تقيم جودة حياتك؟ 
 5 4 3 2 1  )1G(1
 
غير راض   
 مطلقا
لا لا راض و  غير راض
 غير راض
 راض تماما راض
 5 4 3 2 1 كيف أنت راض عن صحتك ؟ )4G( 2
 
 الماضيين  ينالشهرالأسئلة التالية تستفسر عن مدى تعرضك لأشياء معينة خلال * 
 بدرجة بالغة كثير جدا بدرجة متوسطة قليلا لا يوجد  
إلى أي حد تشعر بأن الوجع يمنعك من القيام  )4.1F( 3
 تريدها ؟بالأعمال التي 
 5 4 3 2 1
كم تحتاج من العلاج الطبي لتتمكن من القيام  4)3.11F(
 بأعمالك اليومية ؟
 5 4 3 2 1
 5 4 3 2 1 إلي أي مدى تستمتع بالحياة ؟ 5)1.4F(
 5 4 3 2 1 إلي أي مدى تشعر بأن حياتك ذات معنى ؟ 6)2.42F(
 5 4 3 2 1 كم أنت قادر على التركيز ؟ 7)3.5F(
 5 4 3 2 1 كم تشعر بالأمان في حياتك اليومية ؟ 8)1.61F(
 5 4 3 2 1 إلى أي حد تعتبر البيئة المحيطة بك صحية ؟ 9)1.22F(
  
  
 701
 الأسئلة التالية تستفسر عن مدى قدرتك على إتمام أمور معينة خلال الأسبوعين الماضيين *   
بدرجة  قليلا لا يوجد  
 متوسطة
 بدرجة بالغة كثير جدا
 5 4 3 2 1 هل لديك طاقة كافيه لمزاولة الحياة اليومية ؟ 01)1.2F(
 5 4 3 2 1 هل أنت قادر على قبول مظهرك الخارجي ؟ 11)1.7F(
 5 4 3 2 1 هل لديك من المال ما يكفي لتلبية إحتياجاتك  ؟ 21)1.81F(
كم تتوفر لك المعلومات التي تحتاجها في حياتك  31)1.02F(
 اليومية ؟
 5 4 3 2 1
 5 4 3 2 1 إلي أي مدى لديك الفرصة للأنشطة الترفيهية ؟ 41)1.12F(
 
 جيده جدا جيدة لا بأس سيئة سيئة للغاية  
 5 4 3 2 1 كم أنت قادر على التجول بسهولة 51)1.9F(
 
الأسئلة التالية تطلب منك أن تعبر عن مدى رضاك نحو جوانب مختلفة من حياتك خلال  * 
  الماضيين الشهرين
غير راض   
 مطلقا
غير 
 راض
لا راض و لا 
 غير راض
راض  راض
 تماما
 5 4 3 2 1 كم أنت راض عن نومك ؟ 61)3.3F(
إلي أي مدى أنت راض عن قدرتك على القيام  71)3.01F(
 بنشاطاتك اليومية ؟
 5 4 3 2 1
 5 4 3 2 1 كم أنت راض عن قدراتك على العمل ؟ 81)4.21F(
 5 4 3 2 1 عن نفسك ؟ أنت راضكم  91)3.6F(
 5 4 3 2 1 كم أنت راض عن علاقاتك الشخصية ؟ 02)3.31F(
 5 4 3 2 1 حياتك الجنسية ؟ كم أنت راض عن 12)3.51F(
 5 4 3 2 1 كم أنت راض عن الدعم أو المساعدة من الأصدقاء ؟ 22)4.41F(
 5 4 3 2 1 كم أنت راض عن أحوالك السكنية ؟ )F4.41(32
 5 4 3 2 1 كم أنت راض عن الخدمات الصحية المتوفرة لك ؟ 42)3.91F(
 5 4 3 2 1 كم أنت راض عن وسائل مواصلاتك.؟ 52)3.32F(
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 ينالشهرالمرات شعرت أو تعرضت فيها لأشياء معينة خلال  من الأسئلة التالية تشير إلى كم* 
 الماضيين
 دائما غالبا جدا غالبا نادرا أبدا  
كم من المرات كانت عندك مشاعر سلبية مثل  62)1.8F(
 الحزن أو اليأس أو القلق أو الاكتئاب ؟
 5 4 3 2 1
 
 هل ساعدك أحد في ملء هذا الإستبيان ؟
 
 
 كم من الوقت إستغرقت لملء هذا الإستبيان ؟
 
 
 هل لديك أي تعليقات حول هذا الإستبيان ؟
 
 
 
 شكرا ً لمساعدتك 
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Annex (10): Academic and managerial approval  
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Annex (11): Helsinki Committee Approval  
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 تأثير ارتفاع ضغط الدم على نتائج الحمل في عيادات وكالة الغوث في محافظات غزة
 إعداد: خليل جميل القطراوي
 إشراف: د. أشرف الجدي
 :الدراسة ملخص
الحمل والولادة هي عملية فسيولوجية طبيعية لدى النساء. ومع ذلك، قد تكون هذه العملية العادية 
يصبن بارتفاع % من النساء 01. في قطاع غزة، نتائج الحملوجود عوامل تؤثر على في معقدة 
تائج . ومن الجدير بالذكر أن ارتفاع ضغط الدم قد يؤثر على الحمل ويسبب نضغط الدم أثناء الحمل
تسمم الحمل على ارتفاع التي تصاب بها الأم قد تكون نتائج السلبية من السلبية لكل من الأم والطفل. 
بعد الولادة، متلازمة هيلب، قبل وما ضغط الدم المزمن، الولادة المبكرة، الولادة القيصرية، نزف ما 
المشيمة، تسمم الحمل، وذمة رئوية، الفشل الكلوي، نزيف  فصالداخل الأوعية الدموية، ان منتشر تخثر
الإجهاض، وانخفاض الوزن عند  ؛نتائج الفترة المحيطة بالولادة ومن. ومن ناحية أخرى، دماغي، الوفاة
الأطفال حديثي  ودخول، ووفيات الجنين داخل الرحم، ولادة مبكرةنمو داخل الرحم، تأخر الولادة، 
 .تالولادة إلى المستشفيا
تهدف هذه الدراسة إلى التعرف على التأثير المحتمل لارتفاع ضغط الدم أثناء الحمل على نتائج 
السلبية للأمهات المسجلات في خدمات الرعاية الصحية للأونروا في محافظات  المضاعفاتالحمل 
 .غزة، من أجل الحد من حدوث نتائج الحمل السلبية وتحسين الرعاية الصحية للأم والطفل
أم  034، على 7102و إبريل  6102جريت دراسة مقارنة تحليلية في الفترة ما بين أغسطس أ
يتابعون لدى المراكز الصحية التابعة للأونروا، والتي قسمت إلى مجموعتين (غير مصابين ومصابين 
أم لكل مجموعة. وقد استخدمت المعاينة  512بارتفاع ضغط الدم في الحمل الأخير)، مكونة من 
. وقد تم استخدام الاستبانة كأداة لجمع البيانات من خلال المقابلة الشخصية بجانب النسبيةقية الطب
البيانات. كما وقد تم استخدام مقياس جودة الحياة لمنظمة الصحة  صحة السجلات الطبية للتأكد من
باستخدام "معامل  العالمية. وقد تم إجراء التحليل الإحصائي لمقارنة النتائج المدروسة بين المجموعات
 الارتباط بيرسون" واختبار "مربع كاي" واختبار "ت".
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اللواتي يعانون و اللواتي لا يعانون لدى الأمهات د فروق ذات دلالة إحصائية و وجوقد اظهرت الدراسة 
 2χ(، و نزيف ما قبل الولادة  )100.0=p ,982.76= 2χ(تعزو لمتغير إنهاء الحملارتفاع ضغط الدم من 
 =2χ( الولادةوالنزف قبل   )300.0=p ,053.8= 2χ(عد الولادة ونزيف ما ب  )100.0=p ,264.71 =
 انفصالفروق ذات دلالة إحصائية بين المجموعتين تعزو إلى ، في حين لا توجد )100.0=p ,518.37
ت دلالة ذا، لوحظت فروق للولادةالمشيمة ومتلازمة هيلب. ومع ذلك، فيما يتعلق بالنتائج السلبية 
 2χ( ، وانخفاض الوزن عند الولادة)31.0=p ,411.6= 2χ(المبكرة بين المجموعتين في الولادة إحصائية 
كما أوضحت الدراسة أن . )440.0=p ,60.4= 2χ(للمستشفيات  حديثي الولادةودخول  )300.0=p ,4.11=
٪ من الأمهات اللواتي 1.97أن الحياة. بالإضافة إلى جودة في فروق ذات دلالة إحصائية هناك 
 ) تم شفاؤهن بعد الولادة. HIP(يعانين من 
تفاع ضغط الدم أثناء الحمل وأظهرت النتائج أن الخطورة تكون أكبر لدى النساء اللواتي يعانين من ار 
 حديثي الولادةدخول ، وانخفاض الوزن عند الولادة، المبكرةيكون لهن نتائج ضارة (الولادة  من أن
ما قبل الحمل، والنزف قبل الولادة وبعدها) مقارنة بالنساء اللواتي لا يعانين من تسمم ، و للمستشفيات
ارتفاع ضغط الدم في قطاع غزة. وأن التشخيص المبكر وجودة المتابعة قبل الولادة تعمل على تحسين 
 الأم والجنين. صحة 
 وقد أوصت الدراسة بما يلي 
اية الصحية للأم والطفل في فلسطين على المستوى الأول، الثاني وضع خطة وطنية لتحسين الرع
 والثالث.
 وضع خطط تثقيفية لتشجع وزيادة وصول السيدات الحوامل لمراكز الرعاية الأولية. 
 تحسين رعاية ما قبل وأثناء وما بعد الحمل والولادة خصوصًا للسيدات المصابات بارتفاع ضغط الدم. 
 .ددات نتائج الحمل السلبية في فلسطينتطبيق أبحاث لدراسة مح
